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The characterization of proteins, peptides, metabolites, and natural products are
crucial to the understanding biological processes, discovering biomarkers, and uncovering
new therapeutic molecules. Tandem mass spectrometry (MS/MS) has proven to be a
high throughput and sensitive tool to assay these molecules, whereby the fragmentation
observed in the MS/MS spectra functions as a reproducible signature for each molecule.
Thus, any acquisition of a molecule’s MS/MS fragmentation can be aggregated into a
reusable collection of observed and annotated MS/MS spectra known as a spectral library.
Due to the reproducibility of a molecule’s MS/MS spectrum, spectral libraries
xviii
have gained traction as a resource for the sensitive identification of newly acquired
MS/MS spectra. Thus, the utility of spectral libraries rests on the reliability of MS/MS
similarity metrics as well as the quality and size of the libraries themselves.
In this dissertation we highlight the computational methods that were developed
to enable the creation of spectral libraries for proteomics, metabolomics, and natural
products discovery. These methods include the aggregation and analysis of the entire
community’s mass spectrometry data along with online computational resources that
crowd-source the annotation and curation of specialized spectral libraries. Further, by
leveraging repository scale mass spectrometry data, we have developed methods to assign
statistical significance to spectral similarity metrics in order to enable the automated
identification of MS/MS data by matching to spectral libraries.
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Chapter 1
Introduction
Mass spectrometry has proven to be a valuable tool in understanding the role
of biomolecules at a molecular level and in guiding drug discovery. Metabolomics
and proteomics [2], the study of metabolites and proteins respectively, have extensively
leveraged mass spectrometry analysis to help elucidate the role of metabolites and
proteins in biological processes. Additionally, proteins and metabolites along with
natural products show promise as biomarkers as well as a source of antibiotics and other
therapeutics [74]. Due to the complexity of biology, many of the discoveries in proteomics
and metabolomics have only been made possible by computational methods. While once
it was possible for a diligent scientist to manually examine all mass spectrometry data,
today, high-throughput instruments are capable of generating hundreds to thousands of
mass spectra in the matter of hours, making manual interpretation impractical [69].
The interpretation of tandem mass spectrometry (MS/MS) data has been a key fo-
cus in computational mass spectrometry research. Though the computational community
has invested heavily in the past several decades on the interpretation of MS/MS spectra,
the success of computational approaches to unambiguously assign an MS/MS spectrum
to a putative structure varies vastly depending on the chemical domain.
In proteomics, amino acids are the building blocks of proteins and are coded for by
three DNA base pairs. Thus, given a genome of an organism we cab compute a proposed
1
2proteome, i.e. a list of proteins translated from the genome [5]. The most common
method to computationally identify proteins is comparing tandem mass spectrometry
data to these genome derived proteome databases, known as database search [26, 49]. A
major limitation of database search is that the software must guess at what the tandem
mass spectrum for a particular peptide will be. Additionally, the space of possible
structures is not clearly defined simply by the genome derived proteome. Post translation
modifications [65] and single amino acid variants (SAAVs) [113] drastically augment
this space. The vast majority of this chemical space does not correspond to molecules
in a biological sample, but presents opportunities for false identifications that also incur
a large computational cost to explore. While there exist database search methods that
attempt to skirt around these issues [73, 115], an alternative approach is to rely on
spectral libraries for identifications. Since spectral libraries are collections of reference
spectra of known compounds that have been previously observed, they avoid the need to
predict fragmentation and also accurately capture the empirical chemical space (including
modifications and SAAVs) observed in data, rather than a combinatorially growing space.
In contrast to proteomics, the metabolomics and natural products fields have not
been blessed with computational techniques quite as successful. Though there exist
several tools for identification of various non-peptidic molecules [24, 85, 3], the lack of
sensitivity, absence of false discovery rate controls, and high computational cost limit
their utility in large scale untargeted experiments. Again, spectral libraries present an
alternative approach which capitalizes on previous discovery efforts. In this space, where
computational tools lack maturity, the case for spectral libraries is even more compelling.
To validate the identification of a molecule requires long and laborious chemical assays
such as Nuclear Magnetic Resonance (NMR), Crystallography, or chemical synthesis.
Though, in many instances this process is unavoidable (e.g. novel compound discovery),
the process is necessary only once. By depositing MS/MS spectra of validated compounds
3in spectral libraries, the community benefits in never repeating these costly validation
procedures.
Spectral libraries provide a way to capture the mass spectrometry knowledge
of a community. This knowledge can be compared to newly acquired MS/MS spectra
to identify them in a sensitive manner [58, 114]. Further, spectral libraries can also
inform experimental design, e.g. constructing targeted single reaction (SRM) monitoring
experiments [54]. Thus the success of spectral libraries as a community resource critically
hinges two factors. First, there must exist appropriate measure of similarity between
library and query MS/MS spectra. While the field has generally converged upon using co-
sine based similarity metrics [88], the statistical meaning of these scores is not estimated.
Chapter 2 presents a method to assign significance to spectrum matching. Second, the
spectral libraries must comprehensively cover all biological molecules of interest. Cur-
rently available libraries in metabolomics/natural products discovery [91, 39, 106] have
fallen short in being comprehensive and have been unable to identify a sizeable fraction of
the community’s data. Chapter 3 highlights an approach and platform that democratizes
and crowd-sources the creation/curation of spectral libraries for metabolomics/natural
products discovery, resulting in a drastic increase in spectral library search utility. In
proteomics, the completeness of spectral libraries is highly dependent on the availability
and diversity of community data as well as the ability to re-analyze these data in a high
throughput manner. Chapter 4 presents a mass spectrometry data repository, the Mass
Spectrometry Interactive Virtual Environment (MassIVE), and how this repository is
enabling the community to share and re-analyze mass spectrometry data in meaningful
ways. Finally, chapter 5 builds on these repository efforts and presents a method to
take advantage of the entire proteomics communitiy’s data and create a reusable peptide
spectral library at repository scales.
Chapter 1, in part is a reprint of the material as it appears in ”Spectral Library
4Searching of Tandem Mass Spectra” as part of the UCSD Computer Science and En-
gineering Research Exam. Wang, M (2013). The dissertation author was the primary
investigator and author of this paper.
Chapter 2
Spectral Library Generating Function -
Significance for Spectral Matching
2.1 Introduction
High throughput identification of peptides and proteins in complex samples is
enabled by tandem mass (MS/MS) spectrometry generation of hundreds of thousands
to millions of spectra, from which many thousands of proteins are typically identified
by matching the resulting MS/MS spectra against genome-derived databases of known
protein sequences [2]. In difference from such database search algorithms [26, 16, 50],
spectral library search approaches [111, 92, 14, 31, 58, 98, 112, 17] identify experimental
MS/MS spectra by matching against collections of previously identified reference spectra
(spectral libraries) and have been consistently found to identify more spectra than database
search whenever the corresponding peptides have reference spectra in the library. But
despite this demonstrated superior sensitivity, the development of methods to determine
the statistical significance of Spectrum-Spectrum Matches (SSMs) in peptide spectral
library searches is still in its early stages.
The most common approach to controlling the False Discovery Rate (FDR) in both
database search [25] and spectral library search [57] is the Target-Decoy approach where
one extends the database/library of true peptides with a complement of sequences/spectra
5
6from ‘random’ peptides and uses matches to the latter to estimate the number of false
matches to true sequences/spectra. But while these FDR approaches continue to be very
valuable in correcting for multiple hypothesis testing in large-scale experiments, they
provide little to no insight on the statistical significance of individual SSMs or Peptide
Spectrum Matches (PSMs). In addition, it has been shown [49, 50, 35] that rigorous
modeling of random PSM scores allows one to determine accurate p-values for true
PSMs and thus substantially improve the performance of database search tools. In this
MS-GF [49] approach, dynamic programming is used to exhaustively determine the
distribution of PSM scores for all possible peptides matched to a given spectrum and then
this distribution is used to determine the probability (p-value) of observing a random PSM
score at least as high as the score of an observed PSM derived from the database of known
peptide sequences. Unfortunately this approach does not have a direct analog in the realm
of spectral library searches - while it is straightforward to traverse the space of all possible
random peptide sequences (as in MS-GF), it remains unclear how to generate and/or
traverse a space of ‘random’ spectra that would be representative of false matches to a true
spectral library. First, truly random spectra1 are easy to generate and could be traversed
in a manner similar to MS-GF but such spectra would be mostly very different from the
spectra that tend to be generated by mass spectrometry instruments and thus p-values
obtained using this background distribution of random spectra would not accurately
reflect the probability of false matches for experimental MS/MS spectra. Second, the
approach used for the generation of decoy spectra [57] in FDR calculations continues to
work well in practice for the generation of small collections of ‘semi-random’ peptide
spectra but it is not sufficient to explore the space of all ‘random’ spectra because it only
considers limited changes to peak masses, allows for no variations in peak intensities and
is completely peptide-specific in that it is based on sequence permutations (and thus not
1For example, all spectra of Euclidean norm 1.0 at a pre-determined fixed resolution for peak intensities.
7applicable to spectra from other types of molecules). Third, SSM scoring and p-value
approaches have been proposed based on statistical models of random SSMs but these
assume uniform distributions of peak masses and either ignore (e.g., hypergeometric
models [112, 17]) or make limited use (e.g., peak ranks in Kendall-Tau statistic [17]) of
MS/MS peak intensities. As a result, even though these approaches use a probabilistic
model and calculate p-values, the underlying assumptions and their results on real MS/MS
data suggest that these don’t represent the statistics of SSMs well enough to increase the
overall number identified SSMs (more details in Results).
2.2 Methods
A spectrum is defined as a set of (mass, intensity) pairs called peaks which are
assigned into uniformly sized mass bins (e.g. 1 Th bins [31]). After transformation 2
a spectrum becomes a vector S with n bins, where each bin Si contains the summed
intensity of all peaks with masses in that bin; all subsequent references to “spectrum”
refer to the respective spectrum’s vector. Given a library spectrum L and a query spectrum
S, the projection spectrum Pro j(S,L) is defined as:
Pro j(S,L) = {Si : (Li > 0),0 otherwise}
All library spectra L are normalized to euclidean norm ||L||= 1.0, as are all projected
spectra:
SL = NormPro j(S,L) =
{
Pro j(S,L)i
||Pro j(S,L)||
}
, where ||Pro j(S,L)||=
√
∑
i
Pro j(S,L)2i
2We note that even though spectrum binning is used here for ease of explanation of our approach,
the actual implementation uses peak lists to improve performance as well as to provide the ability to use
per-peak m/z tolerances.
8The most common spectral similarity function used for spectral matching is cosine
(also known as normalized dot product), defined as follows for vectors of Euclidian norm
1.0:
cos(L,SL) =∑
i
Li×SLi
We define a replicate spectrum R (relative to a library spectrum L) to be a spectrum
of the same molecule as L and acquired under the same or similar experimental conditions
(i.e., charge state, instrument, collision energy, abundance, etc.). Due to stochastic factors
in mass spectrometry fragmentation and instrument measurement error [95], some level
of variation is expected between the intensities of peaks in R relative to the intensities
of peaks in L. We model this variability with a log ratio of ion intensities, log(RLi /Li)
where RL = NormPro j(R,L); this ratio is calculated across all bins in R and L where Li
is not zero.
For all library spectra with replicate spectra in our training datasets, all observed
log ratios were collected into an ion variation histogram. We use this histogram (scaled to
total area under the curve 1.0) as the empirical probability mass function, RatioFreq(r),
of variation in ion intensities for all Li 6= 0 (Figure 2.2A). In difference from varying
intensities, the special cases of ion deletion (i.e., RLi = 0) are modeled separately with
DelFreq = #Deletions∑L∈Library #PeaksL×#ReplicatesL , where #Deletions is the total number of peak
deletions in all replicate spectra, #ReplicatesL is the number of replicate spectra in our
training set of a Library spectrum L, and #PeaksL is the number of peaks in a given
library spectrum L. Combining our model of ion variance, RatioFreq(r), and our model
for ion deletion events DelFreq, the probability Prob(Ri|Li) of observing a replicate ion
intensity Ri given a library ion intensity Li is:
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Figure 2.1. Distributions of variation in ion intensity for (A) high and (B) low TIC
precursors. As illustrated by the differences between (A) and (B), the ion variation
distributions for low TIC precursors tend to be wider than those of the high TIC precursors.
In both cases it is shown in bold blue, the distribution of variation in ion intensities for
the 10% most intense peaks in library spectra and in bold red, the distribution of variation
in ion intensities for the 10% least intense peaks in library spectra, with other deciles
shown in between. Note that the width of the distributions for the top decile distribution
is markedly narrower than the bottom decile distribution suggesting the need to model
the variation of ion intensity differently depending upon a peak’s intensity in the library
spectrum. It should also be noted that the lowest decile distribution shown in (B) in red
is not centered at 0 log fold variation due to the significantly higher deletion percentage
(C) of the lowest decile library peaks in low TIC precursors. The deletion of these peaks
caused all other peaks in the spectrum to increase in normalized intensity, for the entire
spectrum is normalized to Euclidean Norm 1, thus causing a shift in the specific ion
variation distribution.
Prob(Ri|Li) =
 DelFreq if Ri = 0(1−DelFreq)×RatioFreq(log2(RiLi )) if Ri 6= 0
Our goal is to calculate the distribution of cosines scores over all possible repli-
cate spectra within instrument variability of a given library spectrum. To compute the
generating function for each library spectrum, we use RatioFreq and DelFreq. We
consider every possible replicate spectrum R (Figure 2.2B) by exploring all possible
intensity variations of every peak Li to Ri and calculate their aggregate probability and
10
cosine similarity cos(RL,L).
A three dimensional dynamic programming table, LibDP(i,c, p), is used to ex-
plore all possible ion variations, where i is the spectrum vector index, c is the cosine score,
and p is the intermediate euclidean norm value. The value in each cell LibDP(i,c, p)
is the probability of a replicate spectrum obtaining cosine c, having p euclidean norm,
and up to and including ion index i. The recurrence for LibDP(i,c, p) is thus defined as
follows for i = 1..n:
LibDP(i,c, p) = ∑
y=0→p
LibDP(i−1,c−√y×Li, p− y)×Prob(√y|Li)
At (i = 0), before considering any ions from the library spectrum L, every cell
LibDP(0,> 0,> 0) = 0, and when no intensity is used and the cosine score is zero, it is
LibDP(0,0,0) = 1. (See Supplementary Figure 2.2 for an illustration of the recursion).
Since each step i only depends on the values from step i−1, one only needs to
use two two-dimensional matrices of constant size to calculate all LibDP values. The size
of each 2D matrix is nc×np, where nc is the number of cosine bins and np is the number
of intensity bins, each set accordingly to the desired granularity. The time complexity
of computing the entire dynamic programming table is O(nc×n2p×n). The final SLGF
distribution of cosines between a library spectrum and its replicates is extracted from
LibDP(n,∗,1) and normalized to sum to 1. It is necessary to normalize at the end because
of probability mass in discarded replicate spectra of Euclidean norm 6= 1.
The probability that a replicate spectrum R and corresponding library spectrum L
exhibit a cosine less than a threshold is expressed as the following p-value:
ProbL(cos(L,RL)< T )
11
where T can be set according to observed cosines between query and library spectra to
determine the probability of a query spectrum S being a replicate spectrum of L.
We developed a spectral library search tool called Tremolo in order to assess
SLGF’s utility in library search. Since SLGF assesses the quality of a single SSM but
does not correct for multiple hypothesis testing when searching many spectra in a dataset,
in Tremolo, FDR is estimated by the TDA [57]. In brief, decoy spectral libraries were
generated using the peptide shuffle and reposition method to obtain a set of decoy spectra.
For all Target and Decoy library spectra, SLGF distributions were calculated and used in
the subsequent scoring function.
The scoring function of an SSM in the spectral library search between a library
spectrum L identified as Peptide(L) and a query S is:
SSMscore = SLGFe = ProbL(cos(L,RL)< cos(L,SL))×ExpInt(S,Peptide(L))
where we define Se|Peptide(L) to be the subset of peaks from S which are annotated by
peptide of L and
ExpInt(S,Peptide(L)) =
∑i (S
e|Peptide(L)
i )
∑i (Si)
The score SLGFe is also considered in addition to SLGF = ProbL(cos(L,RL)<
cos(L,SL)) because it is a closer comparison to SpectraST [58], which does not consider
co-eluting peptides. In cases of co-eluting peptides, SLGF is able to consider these
spectra because it only uses peaks at m/z values Li 6= 0. Yet since SpectraST penalizes
for co-elution, SLGFe is similarity penalized by the explained intensity term, and thus
SLGFe is used as the scoring function in Tremolo. While SLGF may be useful towards
identification of co-eluting peptides, additional considerations are required to correctly
address co-eluting peptide identification [98] (e.g., addressing multiple molecules per
12
spectrum and FDR on mixture identifications).
2.3 Datasets
The Training dataset was composed of 236 CPTAC [79, 93] Study 6 Orbitrap files
(2,766,504 spectra) and was used to train the distributions of variation in ion intensities.
All spectra were searched with SpectraST v4.0 with a 2 Th m/z tolerance against the
NIST Yeast Ion Trap peptide library (May 2011 build). The decoy spectral library was
created using SpectraST’s own decoy generation feature and the resulting SSMs were
filtered to 1% FDR, yielding 396,526 identified spectra from 18,440 unique precursors.
Replicate spectra in this filtered dataset were matched with their respective library spectra
in the library and ion variance distributions were calculated from these replicates and
library spectra.
Yeast and Human Ion Trap peptide spectral libraries, containing 78,825 and
310,688 spectra repectively, were acquired from NIST (May 2011 Build) and were used
in evaluating spectral library search performance. The shuffle and reposition method
proposed by Lam et al [57] was used to create the decoy spectral libraries for use in
Tremolo’s, SpectraST’s, and Pepitome’s search. SpectraST, Pepitome, and Tremolo
searched the NIST library using a 2 Th precursor tolerance; Tremolo and Pepitome used
a 0.5 Th tolerance to annotate MS/MS peaks.
The Yeast Test dataset from CPTAC was composed of an arbitrarily selected file
from CPTAC Study 6 that was not included in the Training dataset and contained 9,809
MS/MS spectra used for evaluating SLGF’s search of the NIST Yeast Ion Trap peptide
library. A second test dataset, Hela S3 Test dataset, was also used to evaluate spectral
search performance in addition to the CPTAC Yeast Test dataset described above. This
dataset [84] was generated from human HeLa S3 cells, by tryptic digestion, and MS
acquisition was performed by an LTQ Orbitrap Classic yielding high accuracy MS1 and
13
low mass accuracy MS2 spectra. Hela S3 Test contained 11,723 MS/MS spectra and was
searched against the NIST Human Ion Trap peptide library.
For Tremolo peptide spectra library search we find that it is best to perform
library preprocessing. Peaks in library spectra were annotated with the respective peptide
sequence considering b,y,b++,y++ ions [82], their respective single 13C isotope peaks
(+1 Da mass shift), single H2O losses (−18 Da mass shift), single NH3 (−17 Da mass
shift) losses and a ions; all non-annotated peaks and precursor peaks were removed.
Additionally, all peak intensities were transformed by square root in both library and
query spectra.
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Figure 2.2. Spectral Library Generating Function (SLGF) calculation of Spectrum-
Spectrum Match (SSM) significance by modeling instrument variation in peak intensity
measurements in replicate spectra of the same compound. In (A) the empirical distribution
of variations in intensity measurements is assessed and discretized. (B) Every possible
replicate spectrum R is represented by a path through each library peak’s possible intensity
variations, thus representing every possible combination of variations of peaks in library
spectrum L. Note that some replicate spectra (paths) are invalid, i.e. replicate spectra
that do not have Euclidean norm 1; intermediate paths with norm < 1.0 are allowed
during the calculation but paths resulting in euclidean norm 6= 1.0 must be discarded
when calculating the distribution of cosine scores.
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2.4 Results and Discussion
2.4.1 SLGF distribution Evaluation
In calculating the SLGF distributions for each peptide library spectrum, it was
observed that it was more accurate to have 10 different distributions of variation in ion
intensity based on the relative intensity of an ion peak in the library spectrum (instead of
a single distribution for all ion peaks). Figure 2.1 illustrates the significant differences
in the distributions of log-ratio ion variations for the top 10% most intense peaks and
bottom 10% least intense ion peaks (other deciles also shown). Additionally, the ion
variance is also substantially different between replicate spectra from high (≥ 12,000
ions) and low total ion current (< 12,000 ions) precursors. The total ion current (TIC) of
a spectrum is calculated as the total ion current of that MS/MS spectrum. As expected,
low intensity replicates exhibit more variation in ion intensities (i.e., wider ion variation
distributions) than high intensity replicates. Using these two separate models for high and
low TIC precursors, two SLGF distributions are pre-calculated for each library spectrum.
Low and high TIC query spectra are then partitioned and searched separately, with SLGF
p-values calculated from the corresponding SLGF distribution.
The SLGF distributions were visually assessed by comparing against empirical
score distributions using replicates from the Training dataset, and it was found that SLGF
distributions approximated the empirical distributions (See Figure 2.3), but further work
is necessary to enable a more accurate p-value calculation. Thus, we use SLGF p-value
as a score and evaluate its performance in the context of spectral library search.
2.4.2 Peptide Spectral Library Search
To systematically assess the performance of Tremolo as a search tool, we com-
pared it against SpectraST and Pepitome at fixed FDR. SpectraST’s performance exceeded
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Figure 2.3. Empirical vs calculated (SLGF) distributions of cosines between library and
replicate spectra. Empirical cosine distributions are histograms of cosine scores between
a library spectrum and replicate experimental spectra (cos(L,RL) for all available RL).
Examples were selected from NIST Yeast library spectra with sufficient replicates from
the Training dataset to derive an empirical distribution. The probability mass in the
empirical distributions to the left of the theoretical SLGF distribution is mostly caused
by cases of co-elution, leading to lower cosines. The discrepancies of higher cosines
result from SLGF using an average model of ion variation derived from data acquired in
many experiments and laboratories. As such, our average model of ion intensity variation
for certain peptides has variance higher than that of the best calibrated instruments,
thus causing SLGF distributions to expect lower average cosines than some empirical
distributions.
that of Pepitome, and thus we focus our detailed analysis on the comparison with Spec-
traST results. Comparing the sensitivity of Tremolo to that of SpectraST on the Yeast
Test dataset we find that at 1% spectrum-level FDR (as determined by TDA), Tremolo
was able to identify 4,373 spectra versus 3,884 spectra by SpectraST (12.5% more, see
Figure 2.5).
The gain in Tremolo sensitivity can be explained by analyzing the different
components in SpectraST’s SSM scores. SpectraST’s score is SSMspectrastscore = 0.6D+
0.4DeltaD−b, where D is the cosine score between library and query. DeltaD = D1−D2D1
where D1 and D2 are the top and second cosine scores respectively from a set of library
spectra to a query spectrum. It is argued that the larger this DeltaD term, the more the
top candidate stands out from the alternatives, thus implying a greater chance the top
candidate is correct. b is the penalty applied to the score for DotBias scores that are
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Figure 2.4. Distribution of total ion current for unidentified low TIC spectra and spectra
identified at 1% FDR on the Training dataset. A) Low TIC spectra that were not identified
by Tremolo but were identified by SpectraST (in orange) on the Test dataset at 1% FDR.
In blue is the distribution of TICs for SpectraST identifications in the Training dataset and
subsequently used to train SLGF. (B) Distribution of peptide TICs for IDs at 1% FDR on
the Test dataset, with Tremolo shown in yellow and SpectraST in blue. Tremolo is found
to be more sensitive in regions of high TIC (> 12000 ions) but loses some sensitivity in
the very low TIC region. The loss of these identifications is caused in part by the low
TIC ion variation model being trained on spectra mostly in the 5000-12000 ions range
and thus not optimally modeling variation in spectra in the < 5000 ions range.
not preferable. DotBias is defined as DotBias =
√
∑i=1→n L2i ∗(SLi )2
D and intuitively can be
thought of a measure of how much a cosine score is dominated by a few peaks. A score
of DotBias = 1.0 signifies one peak dominates the score and a score of DotBias≈ 0.0,
the cosine contribution is evenly distributed over all peaks. Thus, high DotBias scores
possibly imply dubious matches as there are only a few peaks leading to a high cosine
score. Low DotBias scores also are not preferable as this means many equal intensity
peaks are matching, which most likely would imply noise. SpectraST’s penalty b is tuned
to cause larger penalties for larger and very small DotBias values. In figure 2.6A it is
shown the DeltaD versus the DotBias of all IDs at 1% FDR identified by SpectraST over
the test dataset (orange dots). As expected SpectraST IDs tend to avoid high DotBias as
well as exceedingly low DeltaD. In difference from these, Tremolo-only IDs are shown
in gray dots. These tended towards lower DeltaD and higher DotBias and thus were
missed by SpectraST, because of either low DeltaD (lacking the ability to distinguish
17
between the top two SSMs) or because of high DotBias (cosine score dominated by only a
few peaks). Tremolo, however, is able to identify these low DeltaD spectra because each
possible library match to the query spectrum has a different expected score distribution,
and even though from an absolute cosine perspective there is little difference from the top
and second hit, once the cosine p-value is calculated for each respective library spectrum,
then the scores separate substantially. It is clearly show in figure 2.6B that even though
the DeltaD for these spectra that SpectraST failed to identify was very low (x-axis), the
Tremolo’s delta score (SLGFdelta =
SLGF1−SLGF2
SLGF1
where SLGF1 and SLGF2 are the top
and second SLGFe scores respectively) is considerably higher because of the separation
obtained from SLGF p-values.
The identification of spectra with high DotBias is also enabled by the calculated
cosine distribution. For spectra whose intensities are dominated by very few peaks,
cosines alone are not enough to distinguish between good SSMs and bad SSMs. Since
these spectra are dominated by few peaks, the less intense peaks become especially
informative in how their slight cosine changes (because of matching or not matching
these small peaks) distinguish good and bad SSMs. SLGF’s distributions are able to
capture these slight changes in cosine (i.e. higher SLGF distributions with lower variance)
to correctly identify spectra dominated by few peaks whereas SpectraST penalizes all
spectra that are dominated by a few peaks. In general we observe that the effect of
DeltaD is captured by SLGF’s determination of the appropriate mean cosine per library
spectrum and the effect of DotBias is captured by the variance of the SLGF distributions.
An additional source of IDs that Tremolo was able to recover were spectra that
SpectraST did not consider in its search: spectra that have “negligible” intensity above
500 m/z. These spectra generally came from shorter (6-8mer) charge 2 precursors and
moderate length (8-12mer) charge 3 precursors. While these spectra may be easier to
match to decoys with SpectraST’s scoring scheme, Tremolo is again able to use its
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calculated distributions to identify 198 spectra that SpectraST discarded.
The 671 spectra that were identified by SpectraST and not by Tremolo are shown
in Figure 2.6A as blue dots and exhibit no clear bias for or against DeltaD or DotBias.
Upon closer examination we found that many of the spectra from low TIC precursors that
Tremolo scored poorly seemed to exhibit relatively high cosine scores (∼ 0.85) yet the
SLGF distribution would expect a score significantly higher. However, these cases are
mostly skewed towards very low TIC (< 5000 ions) and our training set of spectra for the
low TIC ion variance models skewed toward higher TIC (Figure 2.4A), thus suggesting
that a larger training set may be required to train ion variance models for precursors of
TIC < 5000 ions.
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Figure 2.5. Peptide spectral library search sensitivity and specificity comparison between
Tremolo, SpectraST, and Pepitome. In (A) the performance of the scoring function SLGF
is shown to be comparable to that of SLGFe, where one explicitly attempts to not consider
mixture spectra (see text for details). This contrasts to the performance of SpectraST in
blue, and Pepitome in orange. (B) Number of spectra identified exclusively by SpectraST,
Tremolo, and by both tools at 1% spectrum level FDR. On this Test dataset, SLGFe
was also found to be more sensitive than SpectraST across the whole range of FDR
thresholds (> 12% increase in IDs at 1% FDR). (C) Number of peptide IDs at 1% FDR
by SpectraST and Tremolo. Tremolo identified 16% more peptides than SpectraST.
Missed identifications by Tremolo on spectra from high TIC precursors separated
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Figure 2.6. Gains of identification by Tremolo over SpectraST through analyzing
SpectraST’s score’s DotBias and DeltaD. Each dot in (A) represents an identified spectra
plotted with DeltaD versus DotBias as calculated by SpectraST. In orange are all the
IDs by SpectraST; in blue are the identifications by SpectraST at 1% FDR that were
missed by Tremolo’s search at 1% FDR; in gray are the identifications by Tremolo at
1% FDR that were missed by SpectraST at 1% FDR. For this third category of spectra,
there is a clear bias towards high DotBias and low DeltaD. It is shown in (B) that
while SpectraST was unable to obtain a large DeltaD for these spectra, Tremolo’s delta
score was high and, since this delta score is not used anywhere in Tremolo scores, it
thus reinforces the assertion that these Tremolo identifications are correct. Tremolo’s
exclusive identifications show that there are classes of spectra that remained unidentified
(low DeltaD and high DotBias) that Tremolo is now able to identify. Note the change of
scale for the DeltaD axis (x-axis) in B as opposed to A; since there were no spectra with
SpectraST DeltaD > 0.35 we opted to omit those regions in the figure.
into several categories as shown in Table 2.1. Many examples of deamidation (a post
translational modification that increases the mass of amino acids N or Q by 1 Da)
were seen throughout our analysis for SpectraST is unable to distinguish between the
two variants of the peptide because of the peak smoothing in SpectraST’s spectrum
preprocessing. However, we were able to distinguish these cases and correctly not identify
them because deamidated versions of spectra were not present in the library. While
identifying modified peptides from unmodified spectra is a worthy goal [6], we argue
that such searches should explicitly identify query spectra as modified variants of library
spectra instead of just reporting them as the same unmodified peptide identification.
Additionally, 63 spectra contained a high number (> 2) of 13C isotope atoms. In
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Table 2.1. SpectraST identifications missed by Tremolo at 1% FDR. There were a total
of 334 high TIC and 337 low TIC spectra that were missed by Tremolo at 1% FDR.
While the numbers are comparable, the proportion of low TIC IDs missed was much
higher as there were only ∼ 1400 low TIC spectra identified by Tremolo at 1% FDR.
This higher percentage of missed low TIC spectra can be attributed to suboptimal ion
variation models for very low TIC spectra as described in the text and in Figure 2.4.
Reason Number of spectra
Low TIC Deamidation or 1 13C 105
Low TIC precursor m/z with > 2 13C 36
Low TIC Other 193
High TIC Deamidation or 1 13C 60
High TIC precursor m/z with > 2 13C 63
High TIC Other 214
Total 671
these cases 13C replaced the more common 12C in the peptide, causing an increase in
precursor mass because of the additional neutrons. The presence of these 13C also affects
the prefix and suffix ions in the MS/MS spectra as they skew a portion of the intensity of
the b,y,b++,y++, etc. ions into peaks of 1 Da higher mass. This distorts the shape of the
spectrum and exaggerates the variance in ion intensities of the query spectrum beyond
what is expected by the SLGF distributions.
Of the remaining 214 other spectra that were not identified by Tremolo at 1%
FDR, we manually examined a representative subset of these cases and determined that
∼ 30% of spectra contained a mixture of two or more peptides. Another ∼ 23% were
matched to library spectra of questionable quality, exhibiting low signal to noise ratio
and a high proportion of un-annotated peaks in the reference spectrum. While we have a
low TIC ion variation model that accounts for low TIC query spectra matched to high
quality library spectra, we could not account for lower quality library spectra since this
information is not readily available. Several of these cases of lower quality library spectra
were replaced in the subsequent release of the NIST yeast IT library indicating that NIST
revisions also concluded that these library spectra were of lower quality. ∼ 28% of the
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spectra were matched to high quality library spectra and exhibited high SSM cosine
scores (∼ 0.85) but SLGF distributions were too strict (e.g., expected mean cosine was
too high), which may indicate that our average model of variation of ion intensities across
all library spectra may not be the most appropriate for specific library peptides resulting
in less reproducible spectra.
Despite marked gains over Pepitome [17] and SpectraST [58], our results suggest
that 3 levels of precursor intensity models (< 5000 ions, 5000−12000 ions, > 12000
ions) may be better suited to model peak intensity variations across the range of precursor
TICs in our sample and could thus further improve Tremolo’s performance (Figure
2.4A). In addition, while our models take into consideration the precursor TIC for query
spectra, it would also be informative to know the precursor TIC of library spectra since
fragmentation patterns in these are also very dependent on precursor TIC. Further studies
will be able to determine the effect of both of these factors through the use of larger
training and reference datasets.
In addition to comparing search performance on the Yeast test dataset, the Hela
S3 Test dataset was searched against the NIST Human Ion Trap spectral library using
both Tremolo and SpectraST. Filtering to 1% FDR, Tremolo was able to identify 7,332
MS/MS spectra compared to SpectraST’s 6,723 MS/MS spectra, yielding a 9% increase
in IDs. In this search, Tremolo further imposed a threshold of a minimum explained
intensity of 0.55. Note that since we calculated the SLGF theoretical distributions for
the NIST human library using the ion variance models trained on the CPTAC training
dataset, the amount of ion variation seemed to exceed what was estimated in the Yeast
training dataset. SLGF theoretical distributions were shifted slightly lower to adjust for
this higher variability in ion intensities, resulting in an additional gain in IDs, bringing
the total gain to 10.5% more. This indicates that some amount of retraining may be
beneficial when using different spectral libraries and experimental conditions.
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Even though we did not explicitly aim to identify mixture spectra (and did not
evaluate it), we note that the proposed SLGF approach is based on matching reference
library spectra to subsets of peaks in query spectra (i.e., normalized projections) and thus
appears to be well suited to determining containment of compounds in mixture spectra.
While a detailed assessment of SLGF’s performance on mixture spectra would require a
more comprehensive evaluation [98], our preliminary results illustrated in Figure 2.5A
show that SLGF’s performance was essentially indistinguishable from that of SLGFe
and thus strongly suggests that SLGF should be suitable for identification of peptides in
mixture spectra.
Despite SLGF’s utility in spectral library search, SLGF theoretical score distribu-
tions are currently unable to capture the multi-modality in empirical score distributions
that are shown in figure 2.3 because SLGF is limited to modeling only one source
of variation, i.e. instrument variability in intensity measurements. Other sources of
variation, such as co-elution and alternate fragmentation pathways, would also need
to be considered in order to obtain more accurate SLGF theoretical score distributions.
Another limitation of SLGF p-values is that these are not usable to directly estimate false
discovery rates in the absence of TDA. Unlike MS-GF’s p-values for the distribution
of false matches, SLGF models the distribution of true matches. Thus, SLGF p-values
could possibly enable the calculation of false negative rates and thus allow one to esti-
mate sensitivity (proportional to area under the curve for true matches) but not accuracy
(proportional to area under the curve for false matches).
2.5 Conclusion
Having been repeatedly found [58, 112, 56, 17] that spectral library searching
performs consistently better than database search of the same peptide identification
search space in high-throughput proteomics, there is now renewed interest in establishing
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statistical methods to further assess the quality of Spectrum-Spectrum Matches (SSMs)
and increase the total number of reported SSM-based identifications. Here we propose a
new Spectral Library Generating Function (SLGF) approach to assessing the significance
of SSMs, show how to rigorously calculate SLGF distributions for any spectrum from
any type of molecule and demonstrate that SLGF-based peptide spectral library searching
identifies significantly more spectra than state-of-the-art alternative search tools. In dif-
ference from database search (and other fields) where statistical significance is estimated
by calculating the p-value of observing a high match score when matching a random
sequence, we circumvent the open problem of defining realistic ‘random’ MS/MS spectra
by instead calculating the p-value of observing a low match score when matching a true
(replicate) spectrum to a known reference spectrum. To achieve this goal, we explicitly
model instrument variation in measurement of MS/MS peak intensities and show how
these can be used to derive theoretical distributions of SSM cosines between replicate
and reference library spectra.
Chapter 2, in part, is a reprint of the material as it appears in Spectral library
generating function for assessing spectrum-spectrum match significance in Journal of
Proteome Research 2013. Wang, M, Bandeira, N (2013). Spectral library generating
function for assessing spectrum-spectrum match significance. J. Proteome Res., 12,
9:3944-51. The dissertation author was the primary investigator and author of this paper.
Chapter 3
Community Analysis and Knowledge
Aggregation for Natural Products
3.1 Introduction
Natural products (NPs) from marine and terrestrial environments, including
their inhabiting microorganisms, plants, animals, and humans, are routinely analyzed
using mass spectrometry. However a single mass spectrometry experiment can collect
thousands of MS/MS spectra in minutes [10] and individual projects can acquire millions
of spectra. These datasets are too large for manual analysis. Further, comprehensive
software and proper computational infrastructure are not readily available and only low-
throughput sharing of either raw or annotated spectra is feasible, even among members
of the same lab. The potentially useful information in MS/MS datasets can thus remain
buried in papers, laboratory notebooks, and private databases, hindering retrieval, mining,
and sharing of data and knowledge. Although there are several NP databases Dictionary
of Natural Products [1], AntiBase [55] and MarinLit [66] that assist in dereplication
(identification of known compounds), these resources are not freely available and do
not process mass spectrometry data. Conversely, mass spectrometry databases including
Massbank [39], Metlin [91], mzCloud, and ReSpect [109] host MS/MS spectra but limit
data analyses to several individual spectra or a few LC-MS files. While Metlin and
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mzCloud provide a spectrum search function, unfortunately, their libraries are not freely
available.
Global genomics and proteomics research has been facilitated by the development
of integral resources such as the National Center for Biotechnology Information (NCBI)
and UniProt KnowledgeBase (UniProtKB), which provide robust platforms for data
sharing and knowledge dissemination [7, 63]. Recognizing the need for an analogous
community platform to effectively share and analyze natural products MS data, we
present the Global Natural Products Social Molecular Networking (GNPS, available at
gnps.ucsd.edu). GNPS is a data-driven platform for the storage, analysis, and knowledge
dissemination of MS/MS spectra that enables community sharing of raw spectra, continu-
ous annotation of deposited data, and collaborative curation of reference spectra (referred
to as spectral libraries) and experimental data (organized as datasets).
GNPS provides the ability to analyze a dataset and to compare it to all publicly
available data. By building on the computational infrastructure of the University of
California San Diego (UCSD) Center for Computational Mass Spectrometry (CCMS),
GNPS provides public dataset deposition/retrieval through the Mass Spectrometry Inter-
active Virtual Environment (MassIVE) data repository. The GNPS analysis infrastructure
further enables online dereplication[91, 59, 42, 60], automated molecular networking
analysis[72, 102, 75, 89, 97, 104, 27, 110], and crowdsourced MS/MS spectrum cura-
tion. Each dataset added to the GNPS repository is automatically reanalyzed in the next
monthly cycle of continuous identification (see Living Data by Continuous Analysis
below). Each of these tens of millions of spectra in GNPS datasets is matched to refer-
ence spectral libraries to annotate molecules and to discover putative analogs (Fig. 3.1a).
From January 2014 to November 2015, GNPS has grown to serve 9,267 users from 100
countries (Fig. 3.1b), with 42,486 analysis sessions that have processed more than 93
million spectra as molecular networks from a quarter million LC-MS runs. Searches
26
against a combined catalog of over 221,000 MS/MS reference library spectra from 18,163
compounds (Supplementary Table C.1) are possible, and GNPS has matched almost one
hundred million MS/MS spectra in all public and private search jobs using an estimated
84,000 compute hours.
3.2 GNPS Spectral Libraries
GNPS spectral libraries enable dereplication, variable dereplication (approximate
matches to spectra of related molecules), and identification of spectra in molecular
networks. GNPS has collected available MS/MS spectral libraries relevant to NPs (which
also include other metabolites and molecules), including MassBank[39], ReSpect[109]
and NIST[76] (Fig. 3.2a, and Supplementary Table C.1). Altogether, these third party
libraries total 212,230 MS/MS spectra representing 12,694 unique compounds (Fig.
3.2b). While this combined collection of reference spectra, provides a starting point for
dereplication, only 1.01% of all spectra public GNPS datasets has been matched to this
collection, indicating insufficient chemical space coverage. Although the NP community
is working to populate this missing chemical space, there is no way to report discoveries
of chemistries in an easily verifiable and reusable format.
To begin to address this pressing need, GNPS houses both newly-acquired ref-
erence spectra (GNPS-Collections) as well as a crowd-sourced library of community-
contributed reference spectra (GNPS-Community). GNPS-Collections includes NPs and
pharmacologically active compounds totaling 6,629 MS/MS spectra of 4,243 compounds
(Fig 3.2b, Supplementary Table C.1, Supplementary Note C.0.1.C.0.2). The GNPS-
Community library has grown to include 2,224 MS/MS spectra of 1,325 compounds from
55 worldwide contributors. While the total number of MS/MS spectra in GNPS libraries
is only 4% of the MS/MS spectra collected in third party libraries, GNPS libraries con-
tribute matches of MS/MS spectra at a scale disproportionate to their size (Fig. 3.2c). The
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Figure 3.1. Overview of GNPS. (a) Representation of interactions between the natural
product community, GNPS spectral libraries, and GNPS datasets. At present 221,083
MS/MS spectra from 18,163 unique compounds are used for the search in the GNPS.
These include both 3rd party libraries such as MassBank, ReSpect, and NIST, as well
as spectral libraries created for GNPS (GNPS-Collections) and spectra from the natural
product community (GNPS-Community). GNPS spectral libraries grow through user
contributions of new identifications of MS/MS spectra. To date, 55 community mem-
bers have contributed 8,853 MS/MS spectra from 5,568 unique compounds (30.5% of
the unique compounds available). In addition, on-going curation efforts have already
yielded 563 annotation updates for library spectra. The utility of these libraries is to
dereplicate compounds (recognition previously characterized and studied known com-
pounds), in both public and private data. This dereplication process is performed on all
public datasets and results are automatically reported, thus enabling users to query all
datasets/organisms/conditions. Automatic reanalysis of all public data creates a virtuous
cycle in which contributions to libraries can be matched to all public data. Combined
with molecular networking (Fig. 3.3), this automatic reanalysis empowers community
members to identify analogs that can then be added to GNPS spectral libraries. (b) The
GNPS platform has grown to serve a global user base of 9,200+ users from 100 countries.
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GNPS libraries account for 29% of unique compound matches and 59% of the MS/MS
matches in public (88% of public+private) data. This indicates that the GNPS libraries
contain compounds that are complementary to the chemical space represented in other
libraries (Fig. 3.2c,d). Moreover, in contrast to third party libraries, spectra submitted to
GNPS-Community libraries are immediately searchable by the whole community, such
that submissions seamlessly transfer knowledge between laboratories (Fig. 3.1a) in a
process that is akin to the addition of genome annotations to GenBank[7].
In order to create a robust library, it is important for submissions to be peer-
reviewed and, if necessary, annotations corrected or updated as appropriate. Reference
spectra submitted to the GNPS-Community library are categorized by the estimated
reliability of the proposed submissions. Gold reference spectra must be derived from
structurally characterized synthetic or purified compounds and can only be submitted
by approved users. Approval is given to contributors who have undergone training.
Training is initiated by contacting the corresponding authors or CCMS administrators.
Silver reference spectra need to be supported by an associated publication, while Bronze
reference spectra are all remaining putative annotations (Supplementary Table C.2). This
type of division of spectra is reminiscent of RefSeq/TPA/GenBank[7, 81] (genomics) and
Swiss-Prot/TrEMBL/UniProt[4, 5] (proteomics), allowing for varying tradeoffs between
comprehensiveness and reliability of annotations defined as Gold, Silver, and Bronze
(Fig. 3.2e).
To enable refinements or corrections of annotations, GNPS allows for community
driven, iterative re-annotation of reference MS/MS spectra in a wiki-like fashion, to
progressively improve the library and converge towards consensus annotation of all
MS/MS spectra of interest. This is a process similar to the iterative annotation of the
human genome (e.g., see series of papers on NCBI GenBank[7]). To date, 563 annotation
revisions have been made in GNPS (Supplementary Table C.3), most of which added
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metadata to library spectra or refined compound names. The history of each annotation
is retained so that users can discuss the proper annotation and address disagreements via
comment threads.
3.3 Dereplication using GNPS
High throughput dereplication of NP MS/MS data is implemented in GNPS by
querying newly acquired MS/MS spectra against all the accumulated reference spectra in
GNPS spectral libraries (Fig. 3.2a). To date, more than 93 million MS/MS spectra from
various instruments (including Orbitrap, Ion Trap, qTof, and FT-ICR) have been searched
at GNPS, yielding putative dereplication matches of 7.7 million spectra to 15,477 com-
pounds. In the second stage of dereplication, GNPS goes beyond re-identification by
utilizing variable dereplication, which is a modification-tolerant spectral library search
that is mediated by a spectral alignment algorithm. Variable dereplication enables the
detection of significant matches to either putative analogs of known compounds (e.g., dif-
fering by one modification or substitution of a chemical group) or compounds belonging
to the same general class of molecules (Fig. 3.3b).Variable dereplication is not available
through any other computational platform. For example, GNPS variable dereplication
has detected compounds with different levels of glycosylation on various substrates. As
MS/MS fragmentation preferentially results in peaks from glycan fragments, it is possi-
ble to detect sets of compounds with related glycans even when the substrates to which
the glycans are attached are themselves unrelated[45]. To date, 3,891 putative analogs
have been identified in public data using GNPS variable dereplication (Supplementary
Table C.4). These 3,891 putative analogs include several unique molecules that could be
user-curated and added to GNPS reference libraries (see Molecular Explorer below on
accessing and annotating putative analogs).
To assess the reliability of the MS/MS matches found by GNPS dereplication,
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Figure 3.2. GNPS spectral libraries (a) The computational resources of the metabolomics
and natural products community fall into two main categories: i) Reference collections
(red dots) of MS/MS libraries and ii) Data Repositories (blue dots). Reference collection
resources are contributors and aggregators of reference MS/MS spectra, some of which
also include data analysis tools, e.g. online multi-spectrum MS/MS search (magnifying
glass icon). Several resources have aggregated MS/MS spectra from various reference
collections (red and blue arrows). GNPS has imported all freely available reference
collections (>221,000 MS/MS spectra) and makes them available for online analyses.
GNPS and several other resources provide both reference MS/MS spectra and data
in an open and free manner to the public (pink caps). (b) Comparison of spectral
library sizes of available libraries (MassBank, ReSpect, and NIST) and GNPS libraries;
GNPS-Collections includes newly acquired spectra from synthetic or purified compounds
and GNPS-Community includes all community-contributed spectra. (c) Searching all
public GNPS datasets revealed that Massbank/ReSpect/NIST libraries matched to 1,217
unique compounds, with GNPS libraries increasing unique compound matches by 41%
(corresponding to 29% of total unique matches) with an accompanying 4% increase in
spectral library size. Overall, GNPS libraries increase the total number of spectra matched
in public datasets by 144% (59% of total public MS/MS matches) and spectra matches
across all GNPS public and private data by 767% (88% of all MS/MS matches). (d) The
distribution of precursor masses in all GNPS public datasets (gray) and compared to the
precursor mass distributions of Massbank, ReSpect, NIST, and GNPS libraries. Though
GNPS libraries have a combined size that is smaller than MassBank/ReSpect/NIST,
GNPS libraries have a higher proportion of molecules in the higher m/z range (e) The
quality of spectrum matches obtained by searching against the available spectral libraries
is assessed by user ratings (1 to 4 stars see Supplementary Table C.4) of continuous
identification results. User ratings of 2.5+ stars for 98%+ of GNPS library matches
compares favorably with the 90% mark for NIST matches.
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GNPS users can rate the quality of matches returned by automated GNPS reanalysis
(see below). These ratings are 4 star (correct), 3 star (likely correct, e.g. could also be
isomers with similar fragmentation patterns), 2 star (unable to confirm the annotation
due to limited information) and 1 star (incorrect) (Supplementary Table C.4). So far,
of the 3,608 matches that have been rated, 139 (3.9%) matches were given 1 or 2 stars
(insufficient information (2.9%) or incorrect (1%)) by user ratings. These percentages
are consistent with the false discovery rates estimated using spectral library searches
of benchmark LC-MS datasets with compound standards (Appendix C.0.3, Fig. C.1,
C.2). Furthermore, these 3,608 match ratings were associated with 2,041 library spectra,
therefore the average rating of a library spectrum can offer insight into the reliability of its
reference annotation, not unlike Yelp ratings for restaurants. Incorrect matches can arise
through either spurious high-scoring matches to library spectra or incorrect annotations
for library spectra. Of the 2,041 library spectra with match ratings, 72 (3.5%) spectra had
average ratings below 2.5 stars. These percentage ratings were further broken down by
spectral library (Fig. 3.2e). We found that for GNPS-Collection and GNPS-Community
libraries, only 29 out of 1746 (1.7%) of the rated library spectra had average ratings
below 2.5 stars. These ratings demonstrate that the perceived reliability of GNPS spectral
libraries compares favorably with established community resources such as NIST and
Massbank, in which 10.5% and 20.1% of the ratings were below 2.5 stars respectively,
and provides confidence that the community curation process is robust and that third party
libraries integrate well with GNPS. The main advantages of searching using GNPS are
the option to run simple or variable dereplication against all publicly accessible reference
spectra, and that community-rated matches can be used to improve the quality of the
reference libraries and matching algorithms. These dereplication capabilities are not
possible with existing published resources.
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3.4 Molecular Networking
Molecular networks are visual displays of the chemical space present in mass
spectrometry experiments. GNPS can be used for molecular networking [72, 102, 75,
89, 97, 104, 27, 110, 36, 70], a spectral correlation and visualization approach that
can detect sets of spectra from related molecules (so-called spectral networks[6]) even
when the spectra themselves are not matched to any known compounds (Fig. 3.3a).
Spectral alignment[102, 36] detects similar spectra from structurally related molecules,
assuming these molecules fragment in similar ways reflected in their MS/MS patterns
(Fig. 3.3b), analogous to the detection of related protein or nucleotide sequences by
sequence alignment. GNPS is currently the only public infrastructure that enables
molecular networking. The visualization of molecular networks in GNPS represents
each spectrum as a node, and spectrum-to-spectrum alignments as edges (connections)
between nodes. Nodes can be supplemented with metadata, including dereplication
matches or information that is provided by the user, such as abundance, origin of product,
biochemical activity or hydrophobicity which can be reflected in a nodes size or color.
It is possible to visualize the map of related molecules as a molecular network[110,
105, 87, 47, 71] (Fig. C.3) both online at GNPS (Fig. 3.3c) or exported for analysis in
Cytoscape[87]. Molecular networking analyses of 272 public datasets (Fig. 3.4a) from
a diverse range of samples reveals that on average 35.2% of all unidentified nodes are
significantly matched to other spectra of related molecules within a cosine score of 0.8
(increasing to 44.7% of all nodes in more exploratory networks with a cosine score of
0.65). This indicates that a large fraction of all unidentified spectra are identifiable if
their or their neighboring nodes reference spectra were available in the reference spectral
libraries.
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Figure 3.3. Molecular Network Creation and Visualization. (a) Molecular networks are
constructed from the alignment of MS/MS spectra to one another. Edges connecting
nodes (MS/MS spectra) are defined by a modified cosine scoring scheme determines
the similarity of two MS/MS spectra with scores ranging from 0 (totally dissimilar)
to 1 (completely identical). MS/MS spectra are also searched against GNPS Spectral
Libraries, seeding putative nodes matches in the molecular networks. Networks are
visualized online in-browser or exported for third party visualization software such as
Cytoscape[87]. (b) An example alignment between three MS/MS spectra of compounds
with structural modifications that are captured by modification tolerant spectral matching
utilized in variable dereplication and molecular networking. (c) In-browser molecular
network visualization enables users to interactively explore molecular networks without
requiring any external software. To date, more than 11,000 molecular networks have
been analyzed using this feature. Within this interface, (i) users are able to define cohorts
of input data and correspondingly, nodes within the network are represented as pie
charts to visualize spectral count differences for each molecule across cohorts. (ii) Node
labels indicate matches made to GNPS spectral libraries, with additional information
displayed with mouseovers. These matches provide users a starting point to annotate
unidentified MS/MS spectra within the network. (iii) To facilitate identification of
unknowns, users can display MS/MS spectra in the right panels by clicking on the nodes
in the network, giving direct interactive access to the underlying MS/MS peak data.
Furthermore, alignments between spectra are visualized between spectra in the top right
and bottom right panels in order to gain insight as to what underlying characteristics of
the molecule could elicit fragmentation perturbations.
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3.5 Living Data by Continuous Analysis
Funding agencies and publishers have called for raw scientific data, including
mass spectrometry data, and analysis methods to be made publicly available where
possible. Consistent with this aim, GNPS datasets usually comprise the full set of mass
spectrometry files produced during a NP research project or the full set of spectra analyzed
for a peer-reviewed publication (Chapter C.0.4). While it is potentially advantageous to
the community for all data to be made public, GNPS user data can remain private until
users explicitly choose to make it public (private data is also analyzable and privately
sharable, with >93 million spectra in >250,000 private LC/MS runs already searched
using GNPS). GNPS has the largest collection of publicly accessible natural product
and metabolomics MS/MS datasets and is the only infrastructure where public data sets
can be reanalyzed together and compared with each other. To date, GNPS has made
272 public GNPS datasets openly available which are comprised of more than 30,000
mass spectrometry runs with approximately 84 million MS/MS spectra. In common with
other public repositories[37, 68], GNPS datasets can be downloaded. However, data
availability on its own does not serve to enable data reuse. GNPS is unique among MS
repositories by enabling continuous identification: the periodic and automated re-analysis
of all public datasets (Appendix C.0.5, C.0.6). This continuous re-analysis, which
incorporates molecular networking and dereplication tools, implements a virtuous cycle
as illustrated in Figure 3.1a. Because GNPS spectral libraries are constantly growing due
to community contributions and continued generation of reference spectra, the number
of matches made by successive re-analyses of public datasets has already grown and is
expected to continue to grow over time (Fig. 3.4b). GNPS users are periodically updated
with alerts of new search results.
For example, a Streptomyces roseosporeus project (MSV000078577) was de-
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posited April 8, 2014. At first, only 7 MS/MS spectra were matched. However as of
July 14, 2015 36 spectral matches have been made to GNPS libraries. Overall, the total
number of compounds matched to GNPS datasets increased more than tenfold, while the
number of matched MS/MS spectra in GNPS datasets increased more than twenty-fold
in 2015 (Fig. 3.4b). GNPS users can also subscribe to specific datasets of interest, rather
like following people on Twitter. When new matches are made, changed, or revoked,
all subscribers are notified of new information by an email summarizing changes in
identification. From April 2014 to July 2015, 45 updates were initiated by CCMS and
automatically sent to subscribers (Fig. C.4). Update emails have led to substantially
more views per dataset, compared to non-GNPS datasets (192 proteomics datasets) de-
posited in MassIVE. Continuous identification not only keeps a single dataset alive, it can
create connections between datasets and users over time. Similarities between datasets
could form the basis of a data-mediated social network of users with potentially related
research interests despite seemingly disparate research fields, rather like the People You
May Know feature on LinkedIn. On average each GNPS user already has 5 suggested
collaborators (Fig. C.5).
3.6 Molecular Explorer
Molecular Explorer is a feature that can only be implemented on living data
repositories and thus exists only in GNPS. Molecular Explorer allows users to find all
datasets and putative analogs that have ever been observed for a given molecule of interest.
We anticipate that this feature could guide the discovery of previously unknown analogs
of existing antibiotics. Public NP data contains more than one hundred unidentified puta-
tive analogs of antibiotics such as valinomycin, actinomycin, etamycin, hormaomycin,
stendomycin, daptomycin, erythromycin, napsamycin, clindamycin, arylomycin, and
rifamycin, highlighting a clear potential to generate leads to discover structurally related
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Figure 3.4. Living data in GNPS by crowdsourcing molecular annotations. (a) A global
snapshot of the state of MS/MS matching of public natural product datasets available in
GNPS using molecular networking and library search tools. Identified molecules (1.9%
of the data) are MS/MS spectrum matches to library spectra with a cosine greater than
0.7. Putative Analog Molecules (another 1.9% of the data) are MS/MS spectra that are
not identified by library search but rather are immediate neighbors of identified MS/MS
spectra in molecular networks. Identified Networks (9.9% of the data) are connected
components within a molecular network that have at least one spectrum match to library
spectra. Unidentified Networks (25.2% of the data) are molecular networks where none
of the spectra match to library spectra; these networks potentially represent compound
classes that have not yet been characterized. Exploratory Networks (an additional 20.1%
of the data) are unidentified connected components in molecular networks with more
relaxed parameters. Thus, 55.3% of the MS/MS spectra at least have one related MS/MS
spectrum in spectral networks, with 44.7% having none. In this 44.7% of the data, each
MS/MS spectrum has been observed in two separate instances and should not constitute
noise. Altogether, this analysis indicates that most of the chemical space captured by
mass spectrometry remains unexplored. (b) In the past year, there has been significant
growth in the GNPS spectral libraries, driving growth in the match rates of all public
data. The number of unique compounds matched in the public data has increased 10x;
the number of total spectra matched has increased 22x; and the average match rate has
increased 3x. It is expected that identification rates will continue to grow with further
contributions from the community to the GNPS-Community spectral library.
antibiotics though the application of GNPS (Fig. C.6, and Appendix C.0.7).
3.7 Conclusion
GNPS provides a community-led knowledge space in which NP data can be
shared, analyzed and annotated by researchers worldwide. It enables a cycle of annotation,
in which users curate data, continuous dereplication for product identification, and houses
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a knowledge base of reference spectral libraries and public datasets.
The transformation of deposited spectra into living data that is enabled by the
GNPS platform could mediate connections between researchers and has the potential
to transform data networks into social networks. Of 1,272 compound identifications
obtained by continuous identification with the GNPS-Community library, 1,063 (83.6%)
were made using reference spectra that were not uploaded by the submitter. In other
words, the vast majority of identifications were enabled by other community members.
This reuse of knowledge and data is analogous to other community-wide curation efforts
including Wikipedia and crowd-sourced dictionaries. Since their initial deposition, 59%
of datasets have an increased number of identifications, with the average dataset more
than doubling the number of identifications since submission (Fig. C.7). GNPS enables
facile sharing of individual analyses and uses molecular networks to reveal connections
between datasets from different laboratories and biological sources that would otherwise
remain disconnected. To date, 3,145 analysis jobs have included files shared between
GNPS users, encompassing 548 unique pairs of individuals collaborations. GNPS recasts
public datasets as conversation starters in a data-mediated social network.
As previously shown in genomics[7] and protein structure analysis[8], the models
of global collaboration and social cooperation that are present in GNPS could empower
scientific communities to collectively translate big data into shared, reusable knowledge
and profoundly influence the way we explore molecules using mass spectrometry.
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Chapter 4
The Mass spectrometry Interactive
Virtual Environment (MassIVE) for
sharing and community reanalysis of
proteomics data
4.1 Introduction
Public data repositories for mass spectrometry based proteomics have grown
immensely in the last decade with the proteomexchange consortium[21] coordinating
the requirements of its member repositories, specifically the PRoteomics IDEntifica-
tions (PRIDE)[96], JPOSTrepo[77], and this resource the Mass Spectrometry Virtual
Interactive Environment (MassIVE) at the Center for Computational Mass Spectrometry
(CCMS) at the University of California San Diego. Even though the total amount of mass
spectrometry data available at these public repositories has swelled to 106 TB for human
data (229TB total), only 9TB (10%) included identifications and even less (4TB) have
controlled false discovery rates (FDR). This severe shortage of identifications limits the
utility and reusability of data for the broader biological sciences community.
Resources such as the Global Proteome Machine Database (GPMDB)[14] and
PeptideAtlas[19] aimed to remedy problem through standard reprocessing pipelines
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and present a distilled version of the identifications. However, these approaches fall
short as the search workflows and results are not presented to the users, thus missing
provenance of the identifications. This obfuscation precludes the community from making
a critical assessment of the claims made by these resources (GPMDB and PeptideAtlas)
on individual datasets.
MassIVE picks up where both primary data repositories and reprocessing re-
sources left off. First MassIVE enables data deposition with visualization of all results as
well as automated re-analysis of public deposited data. Second, MassIVE aims to give a
voice to the community and democratize the re-analysis of these data.
Currently, all analyses presented in proteomics data repositories come from only
two sources: the original dataset submitter or a reprocessing resource (GPMDB and
PeptideAtlas). Even though MassIVE has endeavored to reanalyze a large swath of the
public proteomics data with standard pipelines, having only repositories performing
broad fixed analyses limits the progress that can be made in understanding a specific
dataset. For example, the human draft proteomes[48, 103] were published in 2014
whose claims were critically assessed in subsequent publications[28]. These follow-up
re-analyses do not share a life cycle with the original datasets and scientists in the future
reusing these key datasets will miss out all the community conversation and accumulated
knowledge. MassIVE supports the inclusion of community sourced re-analyses with
each dataset, thus facilitating the accumulation of knowledge that is a prerequisite for
creating a community consensus(Fig. 4.1).
While several laboratories possess the infrastructure and software pipelines to
re-process terabytes of mass spectrometry data, much of the proteomics community
does not – limiting the re-utilization of much of the public data available. MassIVE
aims to empower more of the community to re-analyze existing data to help both the
community reach a consensus about the data as well as further their own work. Backed
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by a cloud scale computational infrastructure at the CCMS, MassIVE provides a set of
analysis workflows to interrogate mass spectrometry data. Today, by offering database
search (MSGF+[51]), proteogenomic search (ENOSI[107]), spectral library search (M-
SPLIT[99]), blind modification search (MODa [73]), SWATH library search (MSPLIT-
DIA[100]), and molecular networks analysis (Maestro), MassIVE begins to give the
community analysis flexibility. Additionally, these analysis workflows are seamlessly
integrated with dataset re-analyses, i.e. the community can attach any search results to
the associated dataset. These features thus recasts public datasets not as static entities,
but rather dynamic and evolving focal points of knowledge aggregation.
The MassIVE repository infrastructure presented here highlights an evolution in
the role of a data repository. Cued by the success of Global Mass Spectrometry Social
Molecular Networkings[101] approaches for the metabolomic and natural products space,
we envision MassIVE will create a more collaborative data centric community fostering
more critical analyses of all the public data.
4.2 Data Sharing
4.2.1 The Mass Spectrometry Virtual Interactive Environment
The MassIVE mass spectrometry data repository provides support for the pro-
teomics community to deposit their raw/processed data and results. Submissions fall
into two categories, partial and complete. While both types of submissions include
spectra, complete submissions require that spectra be available in open formats (e.g. mgf,
mzXML[80], mzML[67]) along with accompanying identification results (e.g. mzID[44],
mzTab[34]) that can support claims made in a publication.
To facilitate complete dataset deposition, file format conversions to open for-
mats are provided for both mass spectrometry (to mzML) as well as identification files
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Figure 4.1. Overview of MassIVE ecosystem. Datasets are imported from Tranche,
PRIDE, and deposited by the proteomics community. Each dataset in MassIVE is
automatically processed to open data formats (mzML). Users can do in depth analysis on
one or a combination of datasets with advance computation workflows (e.g. Database
search, blind modification search, proteogenomics analysis, spectral networks analysis,
etc.). These analyses can be further visualized and compared to existing analyses for
the respective dataset at the spectrum, peptide, and protein levels. MassIVE additionally
automatically analyzes each dataset with a baseline database search (MSGF+) and
attaches each as a reanalysis for subsequent interrogation and search. All results attached
to datasets are imported into the MassIVE Index, enabling the community to query on
the 280M PSMs already indexed.
(to mzTab). Currently, mass spectrometry conversions support Thermo RAW, SciEx
IDA, and SciEx SWATH data. Additionally, we support the conversion of standard tab
separated files (tsv) and mzIdentML identification files into mzTab.
Private MassIVE datasets are given password-protected access to the data for
reviewers, allowing them to visualize, download, and reanalyze the data.
As of May 20, 2017, MassIVE serves 7,806 datasets, containing 108TB of mass
spectrometry data. These 7,806 datasets includes 6,324 Tranche recoveries[90], 639
Proteomexchange[21], 510 GNPS[101], and 333 other datasets.
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4.2.2 Complete Datasets and Provenance
The Proteomexchange consortium[21] aims make data public and reusable by
encouraging the publishing of datasets that include identifications (peptide and protein),
as complete datasets. As a proteomexchange consortium member, MassIVE supports
these goals by offering both complete and partial (lacking identifications) submissions.
To facilitate user submissions of complete datasets, MassIVEs web user interface allows
users to select data, enter metadata, and automatically reconcile filename mappings in
results files. After deposition, complete datasets present online pages for all PSMs,
peptides, and protein identifications – including visualizations of peptide spectrum
matches. In difference from all other online resources, for each PSM, a full provenance
record of each identification links back to a spectrum file and search task (including
parameters if analyzed at CCMS).
Of all 1,412 Proteomexchange human datasets, only 330 (23%) are complete.
However, this accounts for only 13% of the total data size. Furthermore, many of these
complete datasets represent their identifications in formats that breaks the connection
back to the raw data and presents issues for external resources to parse the results (e.g.
prideXML). From 330, only 175 datasets (12% datasets and 9% of data volume) provide
results in an open format connected back to the original peak files. However, the vast
majority (136) of datasets contained identifications where the PSM level FDR was either
high (<1%) or could not be calculated. Out of a total of 40M reported PSMs in complete
datasets, only 15M were in search results that were reported under 1% PSM level FDR
(representing 4TB of data) . Of these 15M, 10M (66%) came from the CPTAC colorectal
set of datasets. With only 4TB of data containing error controlled identifications (of
106TB of human data), there is a need to begin providing identifications for the public
proteomics data with a tightly controlled FDR much more broadly. The MassIVE
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repository addresses this need by enabling the addition of identifications from 1) the
dataset submitter, 2) automated reanalyses of public proteomics data, and 3) reanalyses
generated by the community.
4.3 Live Data
4.3.1 Dataset Owner Updates/Upgrades
At the point of initial deposition, datasets are almost always incomplete (e.g. files
and/or identifications are missing). To provide a path to completeness, MassIVE enabling
dataset owners to augment their datasets after deposition. For example, the MSPLIT-DIA
dataset[100] (MSV000079200) was originally deposited at MassIVE on July 27, 2015,
but after publication the authors amended the dataset on July 28, 2016 with identifications
supporting the publication, upgrading the dataset to complete.
As a repository, the need arises to update and enrich key datasets for the commu-
nity, for example, the human draft proteome from the Pandey laboratory[48] (PXD000561
- MSV000079514) was initially deposited as a partial dataset at a ProteomeXchange
repository (PRIDE). As part of MassIVEs import process, we have restructured the data
and identifications in three major ways. 1. Organized data from a unstructured flat file
layout into one that more accurately reflects the metadata and experimental parameters,
i.e. organized by tissue, instrument, and experiment. 2. The datasets proprietary raw
format were converted into an open format to facilitate its reuse and utility for the commu-
nity. 3. We upgraded this dataset to a complete submission by painstakingly converting
pepXML to mzTab and reverse engineering the filenames present in the identification
files yielding over 10M PSMs as originally reported.
Dataset updates can also be useful even for complete datasets designed for sharing.
For example, the CPTAC proteomic study of human colon and rectal cancer[113] contains
45
95 patient samples. This dataset was initially deposited as ten separate datasets and we
reorganized them into a single dataset logically organized by patient (both the data and
identifications) and further included 30 CPTAC normal colon epithelium samples as
controls. This reorganized and aggregated dataset, complete with original identifications
from the publication vastly improves navigability and facilitates the validation of the
results (MSV000079852).
By taking all these steps to reorganize, enrich, and upgrade key datasets for
the community, we have made it possible to explore the original claims made in their
publication and enable the community to reanalyze/reuse these data/results in their own
research.
4.3.2 Dataset Re-analyses of Datasets
Despite MassIVEs efforts to enrich key datasets for the community, the vast
majority of public proteomics data lacks identifications (>90%). A second source of
identifications is from the community. While each dataset can have an official set of
identifications deposited/updated by the dataset submitter, we give the opportunity to the
community to have a voice about what can be found in datasets, presented in a public and
consistent manner. That is, MassIVE allows the community to attach their own reanalysis
of public data – containing a description and references to open format spectrum files of
the dataset that provides provenance and visualization of identifications.
While it is clear that there might arise conflicting interpretations of the same
MS/MS data, the publishing of a re-analysis of a dataset is one step in teasing these
interpretations into the open. Without a common platform to present and interrogate
conflicting claims, reaching consensus is impossible. By giving such a platform for
the community to express their insights and a method to compare differences in claims
(see results comparison), we provide the tools necessary even to begin to reach a data
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supported consensus.
4.3.3 Broad Re-analysis of Partial Datasets
We aimed to automatically reanalyze the public proteomics data in a error con-
trolled and consistent manner. We acknowledge that other computational resources such
as PeptideAtlas and GPMDB also perform reprocessing of publicly available proteomics
data, but the identification results are not made available for each dataset, thus preventing
a growth of knowledge of a given dataset. While PeptideAtlas has attempted in the past to
perform this, only five such reprocessings exist and the results are only available by FTP
access in zipped files rather than browseable online. In difference, MassIVE reanalysis
results are available and visualizable online as well as available in open identification
formats (mzTab).
First, all spectrum files for datasets are converted to open formats amenable to
MS/MS bioinformatic analysis (centroided mzML). To date, this process has processed
47 TBs (1.06B MS/MS spectra) of human proteomics data and will continue on a periodic
basis. Second, all human datasets were searched against the UniProt human reference
database (May 23, 2016) with MSGF+ at 1% PSM level FDR . Results were attached
to the appropriate dataset as a reanalysis. These reanalyses created error controlled
identifications for 34 TB (770% increase) from 226 datasets (480% increase) with 245M
PSMs (1600% increase). These reanalyses span the several major instrument vendors, e.g.
Thermo QExactive (PXD003903 - MSV000080004), Thermo Velos/Elite (PXD000561 -
MSV000079514), Sciex TripleTOF 5600 IDA (PXD000953 - MSV000079593), Sciex
TripleTOF Sciex TripleTOF 5600 SWATH-MS (PXD001064 - MSV000079937), Bruker
qTOF Impact II (PXD001592 - MSV000079935), etc, and show a significant increase in
PSMs for each of these instrument types (Fig. 4.2a).
This increase in annotation across such a breadth of data provides a baseline
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set of identifications for each dataset to allow the community to have a conversation.
With a standardized analysis pipeline, comparisons of identifications and claims between
datasets is now possible. While these baseline reanalyses do not aim to provide definitive
evidence of existence of proteins, they do allow for the generation of hypothesis for
where certain peptides and proteins might occur. For example, there are 19,314 proteins
that putatively occur in greater than ten datasets and based on the metadata of each of
these datasets, hypothesis can generated and further validated. Finally, these standardized
re-analyses of a wide variety of datasets facilitates comparisons.
4.3.4 MassIVE Search
To explore the 280M PSMs across hundreds of datasets, we introduce MassIVE
Search that allows querying across all error controlled (<1% PSM FDR) dataset iden-
tifications and re-analyses. Across the entire MassIVE repository, 280M PSMs, 10M
variants, 5.9M sequences, and 260 modifications from 12,764 individual results were
imported. All PSMs provide full provenance back to the original dataset and/or reanalysis
and enables visualization for the identifications made. We envision this type of query
can allow users to find where a variant, sequence, modification, or protein occurs. For
example, the proteogenomic SNP event sequence: SALFAQINQGESITHALK can be
found in 562 searches from 29 datasets (including both cancer and normal CPTAC data).
4.3.5 In Depth Re-analysis
4.3.6 In Depth Re-analysis
While the baseline set of MSGF+ database search identifications provides a
starting point for the knowledge of a dataset, we also empower the community to ex-
pand this knowledge by customizing their own reanalysis utilizing MassIVEs online
analysis workflows. As a starting point, users can reproduce and tweak the MSGF+
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baseline searches and customize the search parameters, e.g. proteome database, mass tol-
erance values, post-translational modifications, etc. Further, officially supported analyses
workflows include ENOSI (proteogenomic search), MODa (blind modification search),
M-SPLIT (mixture spectra library search), and Maestro (spectral networks). Applied to
a CPTAC Colorectal cancer dataset[113] (MSV000079852) revealed 260 modification
211 modification masses being observed more than 50 times, 19,728 proteogenomic
events, and 386K spectra as mixtures. Analyzing a single patient’s data with Maestro
(TCGA-AA-3518-01A-11) uncovered a high diversity of variants of peptides in the
sample. 181 peptides have five or more variants, with a maximum of 35 variants per
peptide (Fig. 4.2b).
While all these workflows individually allow for detailed interrogation, further
validation by corroborating identifications is difficult. For example, in order to validate
the novel proteogenomic events, e.g. a proteogenomic nonsynonymous single nucleotide
polymorphism event on the peptide SALFAQINQGESITHALK is corroborated by SSL-
16FAQINQGESITHALK in MODa, to another search, e.g. MODa, can be a laborious
process. With so many different analysis tools looking at the same data, where the
majority of the easy identifications are identical, a comparison tool is necessary to both
at a glance and in depth explore what new identifications and biology can be gleaned
from these differences.
4.3.7 Dataset Updates - Broadcasting
Further, any updates/reanalyses to datasets are also reported to proteomexchange
enabling the whole proteomics community to learn of new knowledge being deposited.
Re-analyses of a dataset are announced to the community via a proteomexchange re-
processed accession (RPXD). Additionally, datasets imported into MassIVE from other
proteomexchange consortium members (e.g. PRIDE) which are updated/reanalyzed at
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Figure 4.2. MassIVE Reanalysis (a) Even though human proteomics data has swelled to
106TB, scarcely 4TB contain reusable identifications with proper error controls. Mas-
sIVE has taken the steps to automatically convert from proprietary vendor formats to
standardized open formats (mzML) and follow up with a standardized analysis pipeline.
The total volume of data with identifications has expanded 16x along with a growth of
15M PSMs to 280M PSMs. (b) Powerful computational workflows from the CCMS
(e.g. proteogenomics search, blind search, mixture library search, and spectral networks)
enable deep analysis of a specific dataset. When applied to a single patients data from the
CPTAC (TCGA-AA-3518-01A-11) project, 129 proteogenomic events, 260 blind modifi-
cations, 2,635 mixture spectra, and thousands of peptide variants. C) MassIVEs Results
comparison visualizes and pinpoints unique identifications and disagreements between
search results. For example, in comparing the CPTAC official standard DB results to the
CPTAC official proteogenomic results, revealed 20,666 unique PSMs from the proteoge-
nomic searches. However, comparing these 20,666 PSMs to ENOSI proteogenomic and
Maestro results revealed that that only a handful could be proteogenomic events for the
majority of these PSMs were already found to be from the UniProt Reference Proteome.
Finally, 20 of these proteogenomics PSMs (denoted as SNVs) could be corroborated by
concordant identifications in Maestros blind search results.
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MassIVE will announce to the community with new identifications and discoveries.
4.4 Data Community
While MassIVE has endeavored to create a baseline set of identifications for all
datasets, in many cases the default search tools and parameters can short of being the
most sensitive tool. For example, iPRG 2012[12] challenged the community to identify
a complex mixture of modified peptides. Identification results from 24 laboratories
examining identical MS/MS spectra from a Sciex 5600 qTof yielded drastically different
sensitivities (Fig. 4.3a). Further, the agreement of of a particular submissions results
to the consensus identification varied from 60% to 99% (Fig. 4.3a) and the consistency
of a consensus identification varied from 50% to 100% (Fig. 4.3b). Due to this great
variability in results from different computational analysis pipelines, the community
must be made aware of this fact. However, these 24 results were hidden in cryptically
organized spreadsheets, making validation and comparison impossible. They were
painstakingly converted to open formats and added as a re-analysis for the iPRG 2012
dataset (MSV000078492), giving transparency to the evaluation process.
To reiterate the need for the community to contribute their own reanalyses, a
SILAC datasets[43] (MSV000080791) PSMs identified increased by 42% and precursors
identified increased by 46% when searched with the sample specific SILAC modifications
compared to the standard MSGF+ broad analysis workflow (Fig. 4.3c). Further, for a
phosophoproteomic study[78] (MSV000080773), including appropriate phosphorylation
modifications increased spectrum and precursors identification rates by 55% and 60%
respectively (Fig. 4.3c).
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4.4.1 Reaching Consensus - Results Comparison
With the huge variety of methods to analyze data and the multiple identification
results for public datasets, e.g. CPTAC Colorectral cancer dataset (MSV000079852),
a detailed comparison of identification results is necessary to determine what is new,
conflicting, and consistent. We address this need with an online results comparison tool
that reveals differences at the PSM, peptide, and protein levels. This can be applied
intra-dataset and inter-tool to determine gains in sensitivity and corroborate extraordinary
claims. Here, identification disagreements at the spectrum level can be uncovered in
order to assess error in identifications or determine corroborating evidence. For example,
in comparing proteogenomics analysis (ENOSI) and blind modification search for a
CPTAC patient, it can be quickly ascertained that 275 PSMs from novel proteogenomic
events break down into 64 matching PSMs, 168 mismatching PSMs (same spectrum,
different identifications), and 89 unique PSMs to proteogenomics.
We applied our online results comparison CPTAC official proteogenomic results
for patient TCGA-AA-3518-01A-11. In comparing to the standard database search,
Maestro reanalysis, and ENOSI reanalysis, revealed that out of a total of 65,723 PSMs
in the published results, only 39 remaining PSMs could be novel proteogenomic events
(Fig. 4.2c).
Further, overlap and uniqueness of peptides and proteins (can be remapped to a
common proteome) are determined. Inter-dataset comparisons reveal uniqueness at the
peptide and protein levels of each result set. This can reveal biological and experimental
variation by highlighting expression differences between different conditions, tissues,
and organisms.
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Figure 4.3. MassIVE Community (a) 2012 iPRG community identifications. The wide
variance in number of identifications and deviations from the consensus identification
illustrates the need for the community to be involved in providing identifications for data.
(b) While the majority of consensus identifications have high agreement from community
identifications, a large tail exists and these conflicts will need to resolved and explored
with MassIVEs Results Comparison. (c) Understanding a datasets metadata can have a
large influence on the identification rate of a dataset. By correctly choosing a database
searchs modifications (e.g. SILAC or Phosphorylation) PSMs increased by up to 55%
and precursors increased by up to 60%.
4.5 Discussion
We present the mass spectrometry data repository MassIVE. Data repositories
have long been static institutions that only serve data. However, we envision that data
should take on a life of its own after deposition that continues to bring value to the
community in a more active way. By enabling automated reanalysis, user-initiated
reanalyses, and whose results can be shared and indexed, MassIVE transforms the
communitys past data into a reusable resource. The community can take advantage of
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these reusable data and results, with the powerful analysis/comparison/search tools at
MassIVE to corroborate, validate, and guide future discoveries.
4.6 Methods
4.6.1 Automated Conversions
All MassIVE datasets provide open format (mzML) of all proprietary vendor
formats. Files are converted automatically by the MassIVE system on a periodic basis
through msconvert in Proteowizard. These converted spectrum files are presented in a
special collection for each dataset called ccms peak.
4.6.2 Automated Searches
Public datasets are automatically re-analyzed at CCMS with a standard MSGF+
search workflow. Spectra are searched against Uniprot Human Reference (May 23rd,
2016) and are filtered to a 1% PSM level FDR. Common modifications (Oxidation,
Pyro-Glu, Deamidation, N-term Acetylation) are included in the search and for high
resolution instruments a precursor tolerance of 10ppm is used.
4.6.3 Results Comparison
Two sets of results (A and B) are compared at the spectrum, peptide, and protein
level. At the spectrum level, results are categorized as matching, mismatching, unique
A, unique B. PSMs that identify the same spectrum (filename and spectrum identifier
match) with identical annotations are considered a match. When the annotations are not
identical it is a mismatch. Unique PSMs are to spectra that were not identified by the
other search. Peptides of a search are determined as the set of unique precursors present
in the PSMs. The set of unique A, unique B, and intersection are presented. Proteins
are what the search results reported in the resulting mzTab file. Similarly, unique and
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overlapping proteins are reported. Additionally, peptides may be remapped to a common
proteome in order to compare proteins in the same name space. Unique and overlapping
proteins again are reported.
4.6.4 Results Estimation of FDR
The FDR of a search result file is calculated in one of the following ways:
1. If Q-value column present in the identifications file, maximum q-value of PSMs
reported. Maximum q-value of passThreshold PSMs if input were mzIdentML
2. If decoys are present in results set, total number of decoys divided by the total
number of targets (only including passThreshold PSMS if input were mzIdentML)
3. User entry as part of dataset submission or re-analysis attachement
If none of these conditions apply to an mzTab file, the FDR is undefined.
Chapter 4, in part is currently being prepared for submission for publication of
the material. The Mass spectrometry Interactive Virtual Environment (MassIVE) for
sharing and community reanalysis of proteomics data. Mingxun Wang, Jeremy Carver,
Nuno Bandeira. The dissertation author was the primary investigator and author of this
material.
Chapter 5
Automated Knowledge Aggregation
for Repository Scale Peptide Spectral
Libraries
5.1 Introduction
To map and understand the human proteome is essential in characterizing bio-
logical processes, improving health, and fighting disease. Despite several large scale
proteomics efforts [48, 103, 83] to create draft maps of the human proteome, it remains
impractical for a single study to be fully comprehensive. The enormous diversity of
tissues, cell sub-types, and experimental conditions requires the entire communitys in-
volvement. By leveraging the breadth and depth of the whole fields investigations, can
we begin to build associations of peptide/protein observations to metadata charting the
expression profile of these biomolecules. Further, any comprehensive map of the human
proteome must include detailed provenance for all observations and should be delivered
as a verifiable reusable collection (i.e. a spectral library) of reference spectra to drive
the detection in both shotgun and targeted proteomics experiments, enabling biological
discoveries.
These goals have motivated the construction of large scale spectral libraries
(PeptideAtlas[30], NIST, GPMDB[15]), but unfortunately existing resources were not
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designed to scale automatically with the growing availability of public human data. Thus,
the requirement of manual intervention to update these resources has resulted in outdated
collections that lack detailed provenance records linking library entries to the raw data
and searches used to construct the libraries. The absence of provenance records and
algorithmic details is especially relevant as the field evolves to require more stringent
criteria to control false discovery rates at multiple levels for proteomics discovery.
We propose a new approach and MassIVE-KB resource for the reusable aggrega-
tion of community-scale detection of peptides and proteins observations. Our approach
is composed of multiple steps designed to scale its applicability to all public human
proteomics data (Fig. 5.1a). First, our approach is designed to independently search new
data as it becomes available using only open source algorithms and search procedures.
Second, we build on advanced statistical controls for peptide identifications to automati-
cally adjust the effective search space for each dataset, thereby capturing the statistical
advantage of simpler samples while retaining stringency over the whole range of sample
complexity. Third, we impose additional statistical controls for the community-scale
aggregation of peptide identifications, thereby avoiding the uncontrolled accumulation of
false discoveries. Fourth, our online approach guarantees that incremental extension of
the library yields the same results as full-scale reconstruction, thereby eliminating the
need for time consuming reconstruction when integrating newly available data. Fifth,
all identifications in the library are supported by detailed provenance records linking
each identification to not only the source raw data but also the details of the search
procedure used to derive the results (Fig. 5.1b). Sixth, MassIVE-KB is readily reusable
with existing search tools, including both traditional data dependent (MSPLIT[99]) and
more recent data-independent (MSPLIT-DIA[100]) acquisition modes as well as other
popular tools such as Skyline[62], SpectraST[58], and ProHits[61]. Lastly, a publicly
accessible pipeline that enables the community to create their own spectral libraries.
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With human HCD proteomics data growing to over 37 TB in public data repos-
itories (Q-Exactive is the largest fraction of human data with over twice as much data
as the next instruments in ProteomeXchange[21]), we demonstrate MassIVE-KB by
have reanalyzing this data and distilling it into community-scale reusable HCD spectral
library resource. The reusable collection included 2.1M precursors from 1,088,645
unique sequence, expanding over previous state of the art HCD libraries by delivering
3x more precursors and 2x more sequences (Fig. 5.2a). Furthermore, MassIVE-KB
expands the set of observed protein products by providing evidence for 723 proteins
previously lacking evidence of protein translation, as well as reporting the expression
of 16,801 proteins across 27,404 mass spectrometry experiments (out of 19,610 total
proteins covered in the current release of MassIVE-KB).
5.2 Aggregation/Search of Human Proteomics Data
The MassIVE-KB human HCD spectral library is built from 227 human datasets
available at the Center for Computational Mass Spectrometry’s (CCMS) data reposi-
tory, the Mass spectrometry Interactive Virtual Environment (MassIVE). Together these
datasets contain 658M MS/MS spectra from 27,404 LC/MS runs totalling 31.4TB -
approximately 85% of all Human HCD Q-Exactive data in ProteomeXchange[21] -
grouped into three broad experimental categories. 1. Whole proteome analysis, 2. Lim-
ited Protein Purification (e.g. Affinity Purification Mass Spectrometry) 3. Synthetic
peptide pools[116] (Fig. 5.1b). This gradient of sample complexity is modeled in the
search search strategies used to analyze these data (Fig. D.1). We aimed to maximize
identification sensitivity by ensuring that the confidence of a spectrum identification is
based not only upon the peptide spectrum match score, but also in relation to the search
space of a given spectrum (as dictated by the experimental procedures). By searching
these data with the open source database search tool MSGF+[52], the proper adjustment
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of the search space improved the database p-value scores up to three orders of magnitude
(Fig. D.2a).
False discovery rates (FDR) in the MassIVE-KB are initially controlled at the level
of the individual dataset searches (1% PSM-level FDR) but also need to be controlled
at the aggregate level in the final spectral library to avoid an otherwise unacceptable
accumulation of errors into a library-scale 28% precursor-level FDR. MassIVE-KB
requirements for global precursor error controls are in difference to current library
resources, e.g. PeptideAtlas[30] applies PSM level FDR controls at a per dataset level
and protein FDR globally, but no explicit controls were described to assess the precursor
FDR used for library creation. Similarly, GPMDB[15] relies on an expectation value
for each peptide but there is no explicit FDR calculation showing whether the threshold
needs to be adjusted. NISTs libraries[23] also do not provide guarantees for library level
false discovery rates at the PSM, precursor, peptide, and protein level.
Searching this HCD human data generated 161,510,925 PSMs. Synthetic peptide
pool PSMs were filtered to 0% empirical FDR in each individual search and at most
1% PSM level FDR in other searches. In aggregating all search results, 1% local FDR
by length at the precursor level and 1% FDR at the protein level [86]. From the 161M
candidate PSMs, spectrum quality (see Filtering Methods), precursor FDR, and protein
FDR filters led to 2,176,235 precursors at an estimated 0.1065% global precursor FDR
(Fig. 5.2 a).
5.3 Construction and Spectrum Quality of Peptide
Spectral Library
For each precursor, the representative library spectrum was chosen from the
top 100 scoring PSMs (capped at 20 PSMs per dataset to prevent over-dominance of
one dataset over others) - 30,160,134 M spectra (universally 0% FDR in the original
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search estimated by target decoy). The representative library spectrum was selected to
be the most similar spectrum to all others from the same precursor (Fig. D.5 and Fig.
D.4b). Of the representatives selected, 1,340,043 came from general proteomics data,
647,797 came from affinity purification, and 188,395 came from synthetics peptide pools,
demonstrating the complementarity of these data sources.
To combat potentially false identification of MS/MS spectra to insufficiently
distinguishable annotations via database search, all library spectra were re-searched with
MSGF+[52] against the reference proteome. PSMs for each spectrum were retained
that exceeded the 1% PSM FDR threshold in the spectrums original search. Library
spectra with more than one distinct annotation are considered ambiguously identified
and are removed from the library (2.5% of precursors), reducing the library to 2,122,890
precursors (Fig. D.4c) called the MassIVE-KB.
To estimate the quality of representative spectrum selection, we created a gold
standard library spectrum from stable isotope labeled amino acids in cell culture (SILAC)
samples[33]. 2,622,224 MS/MS spectra from 30 HCD LC/MS [18] runs were searched
and filtered with strict spectral quality requirements and consistency of fragmentation
of concordantly identified co-eluting light and heavy spectral pairs (<1% psm level
FDR)[108]. The resulting library of light peptides (containing 29,574 precursors) was
compared against NIST’s HCD spectral library and CCMSs HCD library. The two
libraries demonstrated nearly identical similarities to each other and to the expected
similarity distribution between reference library spectra (Fig. D.4a), highlighting that the
MassIVE-KB reference spectrum quality is on par with the state of the art libraries.
The MassIVE-KB libraries also aim to be augmented in an online basis as new
public human data becomes available. The library addition procedure is order agnostic
and is deterministic based upon the input data. The current version of MassIVE-KB has
been augmented ten times, growing from 609K to 2.1M precursors over the past several
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months as the total data in MassIVE-KB swelled from 2TB to over 30TB.
5.4 Library Provenance
As spectral libraries represent the extent a proteome has been observed by mass
spectrometry, the provenance of the spectra in the library are valuable to the community
for both validation and exploration. Though existing spectral library resources make
attempts at preserving provenance information, all seem to fall short to linking back to
the spectra, PSMs, and searches that were used to create the spectral library.
MassIVE-KB attempts to close this gap and provide user access to a full prove-
nance record (Fig. 5.1a). For the entire spectral library, all LC/MS run, search jobs /
parameters, and all intermediate library construction jobs are included. Further, rep-
resentative spectra, spectra considered for representative selection (top 100 candidate
spectra per precursor), and the full set of PSMs in library construction are available
and point back directly to the specific LC/MS run, dataset, PI (Table 5.1), and original
search job/parameters (Fig. 5.1b). This transparency in the library creation process
empowers the community to validate search parameters and check the knowledge in the
spectral libraries against the underlying data. Finally, it provides a springboard for users
to customize their own reanalysis of the data and create their own customized libraries
from existing libraries and existing/new searches.
5.5 Proteome Coverage
The MassIVE-KB spectral library currently covers 19,610 (97.4%) proteins out of
the 20,129 proteins reported in SwissProt (Jan 2, 2017) at a 1% protein FDR. Without the
inclusion of synthetic peptides, MassIVE-KB covers 16,801 proteins (83.4%) contributed
from a wide variety of dataset (Fig. 5.3). This represents a gain over the NIST HCD
peptide spectral librarys (July 20, 2016) 13,261 proteins (no Protein FDR) of 48% and
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27% respectively. At the precursor level, MassIVE KBs 2.1M precursors represent an
increase of 322% increase over NISTs 497K (Fig. 5.2a). This gain corresponds to
a similar 235% gain in unique sequences that increased amino acid coverage of the
proteome by 106% from 2.99M amino acids (26.4% of proteome) to 6.17M amino
acids (54.5%), corresponding to covering 191,037 exons (71%) in the human genome.
These gains in coverage represent a corresponding increase in important sites for protein
function. One such site, glycosylation, serves an important roles in cellular signalling,
especially in immune cells. NISTs peptides currently only cover 856 glycosylation
sites with CCMS expanding 547% to 5,540 glycosylation sites out of a total of 17,042
reported sites by UniProtKB[11]. The majority contribution of these new sites come
from the Bioplex dataset[40], Lung Adenomcarcenoma (PXD002612)[29], human draft
proteomes (PXD000865, PXD000561)[48, 103], and ProteomeTools synthetic data
(PXD004732)[116].
While there do exist some sequences that are unique to NISTs libraries (46,230
sequences), the majority of these sequences are short (<10 amino acids) and represent
a potential gain of 129,261 amino acids (1%) in the proteome (Fig. D.3). Of the re-
maining 46% of the proteome not covered by MassIVE-KB, 1,197,093 amino acids
occur in extremely long tryptic peptides (>40 aa) and are estimated to be uncoverable
by trypsin based bottom up proteomics. Thus, without synthetic peptides, we have ob-
served 5,335,526 (6,167,998 amino acids with synthetics) amino acids, with a remaining
4,869,110 (4,042,347 with synthetics) amino acids remaining in coverable regions (Fig.
5.2d).
5.6 Targeted Proteomics Design
In targeted proteomics experiments, e.g. Single Reaction Monitoring (SRM),
the careful selection of proteotypic peptides is essential to the proper quantification of
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targeted proteins. Previous efforts by PeptideAtlas[53, 64] empirically predicted the most
proteotypic peptides for each protein. Unfortunately, the breadth of PeptideAtlas only
enabled evaluation of 9,946 proteins. Building upon the provenance of all searches in
creating the MassIVE-KB library, we have expanded this set to nearly 17K proteins.
In evaluating the proteotypic-ness of precursors, we observed a wide variance in
the consistency ranging from 0% to 100%. Due to this variance, the number of precursors
per protein that are necessary to observe the protein at least 90% (Fig. 5.4a) of the time
varied from 1 to greater than 20; however, in the majority of cases less than 5 precursors
were necessary (Fig. 5.4b). These measures of consistency on a per protein basis provide
the groundwork to design more sensitive SRM experiments.
Further, library derived sets of proteotypic peptides can probe protein-protein
interactions. 24K protein-protein interactions were reported by Bioplex 1.0[41], and
were filtered down to 11,838 interactions between primary isoforms in swissprot. 9,983
interactions were observed in the data and utilizing the covering set of proteotypic
peptides, these interactions can be observed on average greater than 90% of the time
(Fig. 5.4c). 915 interactions were not observed because of the absence of the protein in
the library. A remaining 924 reported interactions were not observed with co-occurring
proteins within the same sample in our analysis.
5.7 Detecting Unobserved Proteins
The NeXtProt[32] resource aims to be a knowledgebase that catalogs the extent of
the communitys knowledge of human proteins. As such, NeXtProt (Jan 2, 2017) claims
that 16,641 proteins from SwissProt[9] (20,129 total) have been previously observed with
protein evidence (PE1). Of these, 15,666 proteins were observed in the MassIVE-KB
without synthetics at a 1% protein FDR (94% PE1 proteins). The remaining 6% of
proteins anecdotally observed to be from labeled quantification (iTRAQ) experiments
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and datasets (P98073), NeXtProt peptide evidence was not provided (P61578), or only
observed in synthetic experiments (Q69383). We envision as more HCD data is generated
and included in MassIVE-KB library, these remaining proteins will become part of the
library.
NeXeProt claimed the remaining 3,488 proteins (PE2-PE5) to lack proteomics ev-
idence. 723 of these 3,488 proteins were observed in the MassIVE-KB library originating
from non-synthetic data with at least two non-overlapping sequences that could not map
to another protein as a single amino acid variant (SAAV). The majority (649 proteins)
were previously seen with transcriptomic evidence (PE2) with the remaining 32 inferred
from homology (PE3), 12 uncertain (PE4), and 30 predicted (PE5) (Fig. 5.2c). 531 newly
observed proteins contained peptides that could be validated against a synthetic peptide
library generated from ProteomeTools[116] (Fig. 5.2b). The common precursors demon-
strated very high spectral similarity, with minimum cosine scores of 0.7, and a median of
0.93 (Fig. 5.2c). 308 proteins contained at least two non-overlapping precursors, meeting
US HUPOs Extraordinary Detection Claims[22] (Fig. 5.2b). Additionally, 302 of these
723 proteins were observed to have to have peptides derived from AP-MS Bioplex data.
267 of these proteins were observed in samples matching the exact same bait protein,
reinforcing that these previously unobserved proteins peptides are indeed correct. Finally,
the protein FDR of all proteins with at least two non-overlapping sequences not mapping
to an SAAV was 0.013% estimated by TDA.
5.8 Knowledgebase Redistribution
The MassIVE-KB HCD spectral library is made to be redistributed and reused in
several ways (Fig. 5.1b). 1. Downloaded as an annotated MGF for use with ProHits[61]
and for further computational reanalyses. 2. Downloaded as an sptxt library file for use
with SpectraST[58] in the Trans Proteomics Pipeline[20], and Skyline[62]. 3. Used in
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CCMSs computational workflows engine for online library searching of data. These tools
include M-SPLIT[99] (Data Dependent Acquisition Spectral Library Search), MSPLIT-
DIA[100] (Data Independent Acquisition Peptide ID), and Maestro (Spectral Networks
Analysis). Searching a HEK293 dataset[13] containing 1.1M MS/MS spectra with M-
SPLIT showed MassIVE-KB identified 64% more precursors than NISTs HCD library
(Fig. D.6).
5.9 Discussion
We have presented a platform that aggregates the community data into a reusable
knowledge base - MassIVE-KB, in the form of a spectral library. This error controlled
distillation of the communitys HCD data enables the measuring of progress to completion
of proteomes. As new studies and data is deposited in ProteomeXchange consortium mass
spectrometry data repositories (e.g. MassIVE, PRIDE, JPost), they will be automatically
and appropriately searched and appended to the existing spectral library in an online and
error controlled manner.
While the MassIVE-KB spectral library is a general purpose resource for the
proteomics community, we envision the communitys need for bespoke spectral library
for more targeted and niche purposes. We provide the exact workflows to search and
create the MassIVE-KB spectral libraries to the community. Leveraging the provenance
of the MassIVE-KB spectral libraries, the community can use the existing searches and
library creation workflows as a starting point to create their own distilled and reusable
library resources.
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5.10 Methods
5.10.1 Data Origin and Preparation
All HCD data was either deposited at MassIVE or PRIDE[96] (and subsequently
imported). The Bioplex dataset was acquired directly from the Bioplex project. All
thermo raw files were converted using proteowizards msconvert[46] to centroided 32-bit
mzXML or mzML[67] files and made available as part of the respective dataset on
MassIVE. The initial creation of the CCMS library included 227 datasets, totalling over
30TB of data. The dataset list is in SI Table Input Datasets and all datasets are publically
available on MassIVE.
5.10.2 Single Pass Search
The spectra are searched by MSGF+. The UniProt human reference proteome
database (May 23, 2016) used contains ∼ 70K proteins. Allowed modifications are
oxidation, n-term acetylation, n-term Carbamylation, Pyro-glu, and deamidation. Car-
bamidomethylation is a fixed modification on cysteine. Allowed 1 C13 and 1 non-
enzymatic termini and a 10ppm parent mass tolerance. Each individual search is filtered
to 1% PSM level FDR.
5.10.3 Dynamic Search Space Adjustment Search
In order to improve the sensitivity of searches and take advantage of the experi-
mental metadata, we created a dynamic search space adjustment search. Since MSGF+
reports a database p-value[35] that takes into account both the quality of the peptide-
spectrum-match and the search space, using a more appropriate search space will improve
database p-value of peptide spectrum matches.
While the search space of synthetic peptide pooled runs are defined prior to a
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search, for the class of datasets where there is a limited set of proteins (by purification or
separation), that search space of proteins is discovered and utilized to boost certain PSM
database p-value scores.
In this first phase, spectra are searched by MSGF+ UniProt proteome database
(May 23, 2016) containing 70K proteins. Allowed modifications are oxidation, n-term
acetylation, n-term Carbamylation, Pyro-glu, and deamidation. Carbamidomethylation
is a fixed modification on cysteine. Allowed 1 C13 and 1 non-enzymatic termini and a
10ppm parent mass tolerance. Search results are filtered to 1% spectrum level FDR. A
subset of the proteins from the database are selected such that each protein has at least
two distinct sequences from identification set. Proteins with two or more peptides are
collected. Input spectra are re-scored against this reduced protein set to update database
p-values for spectra identified to these proteins in both stages. All other PSMs will have
their database p-value scores unchanged. Results are then filtered to 1% PSM level FDR
with database p-value as the primary score ranking.
5.10.4 Synthetic Searching
Synthetic spectra from ProteomeTools[116] were run in 365 pools of 1,000
peptides. Each pool of 1,000 peptides was acquired multiple times. Each LC/MS run per
pool was searched separately by searched by MSGF+ (except the DDA sighting run). 10
random LC/MS runs from ProteomeTools were searched together as a background. These
LC/MS runs were searched against the per pool specific database of peptides. All PSMs
were merged and sorted by descending database p-value. A decoy PSM was defined as
1. A target or decoy PSM matched to an LC/MS run from the background files
2. A decoy PSM matched to an LC/MS run from the desired pool
PSM results were filtered to 0% FDR.
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5.10.5 Spectra Extraction/Filtering
All filtered PSMs per search are considered eligible to enter the spectral library.
For each PSM, the corresponding MS/MS spectrum is extracted from the appropriate file
and match statistics are calculated. Each spectrums peaks are normalized to a euclidean
norm of 1.0. All peaks are annotated by the PSM peptide sequence with the ions ”b”,
”b-iso”, ”y”, ”y-iso”, ”b-H2O”, ”b-NH3”, ”y-H2O”, ”y-NH3”, and ”a” with charges up to
and including the precursor charge with a mass tolerance of 0.1 Da. Any spectrum with
an explained intensity of less than 0.4 were discarded. Further, any MS/MS spectrum
that deviated from the theoretical mass by more than 50ppm were filtered out, including
any C13 isotopes.
5.10.6 Spectral Library Precursor Selection for Inclusion
For each precursor, the top 100 scoring spectra are retained (with a maximum of
20 per dataset) for future consideration. Each precursor is scored with the best database
p-value of its PSMs and these precursors are filtered to 1% local precursor FDR by length.
Multiple precursors that differ only by site localization of modifications were removed
with only the highest scoring precursor retained. Further precursors are then mapped to
the SwissProt Human Proteome (Jan 2, 2017). Protein level FDR is performed with only
non-shared precursors. Each protein is scored as the sum of the -log10 of each precursors
database p-value that maps to it. Proteins are filtered to 1% Protein FDR. All precursors
(including shared sequences) that map to at least this filtered protein set are retained,
others are dropped.
For each peptide length we determined the worst database p-value score at the
FDR threshold to define a PSM cutoff threshold. All PSMs below this threshold were
dropped. Of the remaining spectra for each precursor, the spectrum most similar (by
cosine) to all others in this set is selected as the representative library spectrum.
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5.10.7 Online Spectral Library Augmentation
New datasets are converted to open formats, searched with a standard database
search workflow, and spectra are extracted. All new annotated spectra are merged together
with the existing top 100 PSMs per precursor and again filtered to 1% precursor level local
FDR with a new database p-value score cutoff for each length. The spectra remaining in
contention are treated similarly to initial library creation. This procedure ensures order
independence of dataset addition.
5.10.8 Filtering out Ambiguous Library Spectra
Library spectra are searched against the UniProt human reference proteome
database (May 23, 2016) by MSGF+ with identical settings as the original database
search. The top 20 identification candidates are returned for each library spectrum.
For each library spectrum, we retain identification candidate if it exceeds the 1% PSM
FDR cutoff score in the library spectrums original search. Identification candidates that
differ from the highest scoring identification candidates by site localization of PTMs are
removed. Library spectra with multiple identification candidates are considered to be
ambiguous and are removed from the library.
5.10.9 Novel Protein Calling
Precursors greater than length 8 are mapped to the SwissProt (Jan 2, 2017) Human
Proteome and filtered to 1% Protein FDR via the picked Protein FDR method[86]. Further,
these precursors are mapped to proteins, allowing for a single amino acid variant (SAAV).
Peptides mappings to multiple proteins are removed. For each protein, the number of
non-overlapping peptides is counted. Only proteins with at least two non-overlapping
peptides and fall under 1% Protein FDR are candidates for novel protein observation.
Each proteins NeXtProt PE level is identified, and PE1 proteins are not reported.
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Table 5.1. Top Contributing PIs to MassIVE-KB
PI Top 100 Candidate Spectra Representative Spectra
Steven Gygi 3,556,504 (12%) 660,801 (30%)
Bernhard Kuster 4,570,424 (15%) 252,229 (12%)
Matthias Mann 4,875,236 (16%) 224,867 (10%)
Akhilesh Pandey 2,356,169 (8%) 172,966 (8%)
Christopher Gerner 1,156,998 (4%) 66,701 (3%)
5.10.10 Gold Standard Library Construction
SILAC datasets were searched MSGF+ and variable SILAC modifications of
+8,+10 on Arginine and Lysine. Results were filtered to 1% PSM level FDR. Next we
determined concordant light and heavy pairs of MS/MS spectra. They had to fulfill the
following criteria:
1. Light and heavy MS/MS spectra had to exhibit exact same peptide annotation aside
from SILAC modification
2. Aligned cosine score of greater than 0.6
3. Explained Intensity greater than 0.5
4. Retention time within one minute
Light version of validated light/heavy pairs are considered for the SILAC library.
The highest database p-value scoring spectrum for each precursor is selected to be the
representative in the library.
Chapter 5, in part is currently being prepared for submission for publication of the
material. Assembling the Community Scale Discoverable Human Proteome. Mingxun
Wang, Jian Wang, Jeremy Carver, Nuno Bandeira. The dissertation author was the
primary investigator and author of this material.
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Figure 5.1. Overview of MassIVE-KB (a) Representation of the interactions between
the proteomics community, MassIVE datasets, MassIVE Index, and MassIVE knowl-
edge base. This eco-system empowers a user by guiding experimental design with a
spectral library (e.g. designing an SRM experiment), making identifications in their own
LC-MS/MS data by spectral library search, and validate extraordinary results against
reference library spectra and all PSMs found in all public data via MassIVE Index. The
MassIVE-KB spectral library draws from over 30 TBs of data with 658M MS/MS spectra
yielding 161M PSMs resulting in a spectral library of 2.1M precursors. New HCD
human datasets are added to the MassIVE-KB in an online fashion upon deposition
in ProteomeXchange consortium repositories. Further, the community can review the
knowledge in MassIVE-KB in order to scrutinize the full provenance record and request
changes with supporting information. (b) Overview of library creation procedure. Be-
ginning with different search strategies for different experimental procedures. PSMs
and aggregated and filtered for spectrum quality. Precursor level FDR is applied on the
remaining spectra that filter candidate spectra for inclusion in the library. Representative
spectra are chosen and ambiguously identified spectra are removed. The MassIVE-KB
spectral library is made available to browse, search new data, and download in both mgf
and sptxt formats.
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Figure 5.2. MassIVE-KB Coverage of Human Proteome (a) The MassIVE-KB HCD
spectral library expands over NISTs HCD library by 323% for precursors, 235% for
sequences, and 106% for proteome coverage. Further, in comparison from other available
spectral library resources, MassIVE-KB controls library level FDR at the precursor and
protein levels along with provenance information for each library spectrum. (b) 723 of
3,489 proteins not observed with proteomics evidence from NeXtProt were detected
with at least two non-overlapping sequences in the MassIVE-KB. 531 proteins could be
confirmed with synthetic peptides with 308 proteins matching 2+ synthetic sequences
(green) and 223 proteins matched with 1 synthetic sequence (blue). (c) The library spectra
calling these unobserved proteins confirmed by synthetic MS/MS spectra exhibited high
spectral similarity with a minimum score of 0.7 and a median of 0.93. (d) Even with the
marked gain in coverage by the MassIVE-KB of the human proteome, there remains 4M
amino acids that are coverable (<40 amino acid tryptic sequences). This represents 3.4M
amino acids remaining in observed proteins in MassIVE-KB (without synthetics) as well
as 625K amino acids in unobserved proteins.
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Figure 5.3. Growth of Proteome Coverage. Various datasets in the community contribute
their own unique picture of the human proteome. Several foundational datasets , e.g. Bio-
plex and draft proteomes, provide vast comprehensive coverage of commonly observed
proteins. However, several smaller datasets contributed unique proteins, e.g. PXD004927
SUMO proteome[38] and PXD003947 spermatozoa[94] proteins. All combined, the
communities dataset (excluding synthetics) observe nearly 17K proteins of the human
proteome.
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Figure 5.4. Proteotypic Peptides in Proteome (a) The percentage observability for
proteins given a selected proteotypic peptide set. In the vast majority of cases (98%),
proteins could be observed in >90% of searches with a selected set of proteotypic
peptides. (b) The number of peptides that must be selected such that at least one peptide
is present 90% of the time when a protein is called. For the majority of cases, less than
four precursors is required to observe a protein in 90% of its occurrences. While there
does exist a tail, upon closer investigation, a subset of datasets proteotypic peptides differ
drastically from the norm. This discrepancy can be partially attributed to experimental
procedures for peptide enrichment (e.g. phosphorylation and SUMOylation). (c) The
protein-protein interactions as reported by the Bioplex project can also be detected with
a subset of the peptides in the identifications. By using the top peptides that can call a
protein >90% of the time, >88% of observed interactions can be called >90% of the
time with this proteotypic peptide set.
Appendix A
SLGF Dynamic Programming Details
LibDP(i,c, p) = ∑
y=0→p
LibDP(i−1,c−√y×Li, p− y)×Prob(√y|Li)
In the equation for the LibDP recurrence, c−√y ∗Li is used because we are
iterating over all possible increments in spectrum norm. For each increment y (third
term in the LibDP recurrence, p− y ), this translates into a √y intensity for the replicate
spectrum peak. Thus if we consider
√
y intensity in a replicate spectrum peak, such a peak
will contribute
√
y×Li to the accumulated cosine c between the replicate and the library
spectrum L, which explains the second term in the LibDP recurrence: (c−√y×Li).
CPTAC Test Dataset Search with Sigma UPS1 search
In the initial analysis, the search library did not include Sigma48UPS1 spectra.
To determine whether this affected the search results, the search was re-performed with
the combined NIST Yeast and Sigma libraries. Supplementary Figure A.2 includes ROC
curves for this search of the Test dataset against this combined library. At 1% Peptide
FDR, Tremolo had 3902 IDs, and SpectraST had 3315, representing a 17% gain. The
results show the relative difference between Tremolo and SpectraST to be comparable to
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Figure A.1. SLGF calculation example using the LibDP dynamic programming recursion.
In (A) a very simple library spectrum with only two peaks is considered (with intensity
0.4 and 0.91). Each of these peaks has identical deletion frequency and intensity variation
distributions that are discretized to 0.4x, 1.0x, and 2.5x intensity, with 0.25, 0.5, and 0.25
probability respectively. In (B) the dynamic programming recurrence is illustrated with
the probability of occurrence shown in each cell (0.0 if empty). The arrows represent
the propagation of probability and the color of each arrow represents which portion of
the intensity variation distribution yielded the probability update. The last column of
the table for the last peak (i=2 in this case) corresponds to the distribution of cosine
scores at Euclidean norm 1.0 (shown in purple). This last column is re-normalized to
total probability 1.0 and used as the SLGF theoretical score distribution for the library
spectrum. The calculation of the ∆Cosine and ∆Norm is shown in (C), which explains the
differing indices for the dynamic programming for the dynamic programming recurrence
between i=1 and i=0. Additionally, the calculation of the probability of the top left cell
(shown in yellow) for the i = 1 peak is shown in (D). Note that while it is shown that
the LibDP matrix has np = 4 and nc = 4, the actual implementation uses np = 400 and
nc = 800.
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that of the search without the Sigma library.
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Figure A.2. SLGF Yeast ROC Curve. Peptide spectral library search sensitivity by
FDR comparison between Tremolo and SpectraST on the CPTAC Test dataset with the
combined NIST libraries for Sigma and Yeast. At 1% spectrum level FDR, the gain in
IDs for Tremolo is approximately 11%.
Appendix B
GNPS Methods
B.0.1 Spectral Library Searching
Input MS/MS spectra (i.e., query spectra) are considered matched to library
spectra if they meet the following criteria: same precursor charge state, precursor m/z
is within a user defined Thompson tolerance, share a minimum number of matched
peaks, and exceed a user-defined minimum spectral match score. Exact spectral matches
between library and query spectra are scored with a normalized dot product5759. The
matching of peaks between two spectra is formulated as a maximum bipartite matching
problem15 where peaks from the library and query spectra are represented as nodes
with edges connecting library and query peaks. Edges connect peaks that are within a
user defined fragment mass tolerance. The bipartite match of library to query peaks that
maximizes the normalized dot product is selected. The highest scoring library match for
each query spectrum is reported. Estimated false discovery rates of the exact spectral
library search are shown in Supplementary Note C.0.3. Source code can be found at the
CCMS github page.
B.0.2 Variable Dereplication
Variable dereplication utilizes a modification tolerant spectral library search.
Similar to exact spectral matches, except additional edges are added to the bipartite
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matching between library and query peaks which differ by a δ (as determined by their
precursor mass difference δ ) +/- the user defined fragment mass tolerance.
B.0.3 Molecular Network Construction
Molecular networks can be constructed from any collection of MS/MS spectra.
First, all MS/MS spectra are clustered with MSCluster60 such that MS/MS spectra
found to be identical are merged into a consensus spectrum. Consensus spectra are then
matched against each other using the modification tolerant spectral matching scheme15.
All spectrum-to-spectrum matches that exceed a user defined minimum match score are
retained. MS/MS spectra are then represented as nodes in a graph and significant matches
between spectra are represented as edges. Further, edges in the graph are only retained
if the two nodes, A and B, connected by a given edge satisfy the following properties:
i) B must be in the top K highest scoring neighbors of A and ii) A must be in the top K
highest scoring neighbors of B. All other edges are removed. Source code can be found
at the CCMS github page.
B.0.4 GNPS Collections - Sample Preparation
The NIH Prestwick Phytochemical Library, NIH Natural Product Library, and
NIH Small Molecule Pharmacologically Active Library compounds were received as
stock solutions of pure compounds (10 mM in DMSO). They were reformatted by 1 L of
each compound into 89 L of methanol into 96 well plates with 11 distinct compounds in
each well. They were further diluted 100-fold for a final 1 M concentration. The NIH
Clinical Collections and FDA Library part 2 were received as stock solutions of pure
compounds (10 mM in DMSO). They were diluted to final concentration of 1 M in 50:50
methanol:water and formatted onto 96 well plates with 10 compounds per well.
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B.0.5 GNPS Collections - LC MS/MS Acquisition
LC-MS/MS acquisition for all in house generated libraries was performed using a
Bruker Daltonics Maxis qTOF mass spectrometer equipped with a standard electrospray
ionization source (ESI). The mass spectrometer was tuned by infusion of Tuning Mix
ESTOF (Agilent Technologies) at a 3 L/min flow rate. For accurate mass measurements,
lock mass internal calibration used a wick saturated with hexakis phosphazene ions (Syn-
quest Laboratories, m/z 922.0098) located within the source. Samples were introduced
by a Thermo Scientific UltraMate 3000 Dionex UPLC using a 20 L injection volume.
A Phenomenex Kinetex 2.6 µm C18 column (2.1 mm 50 mm) was used. Compounds
from NIH Prestwick Phytochemical Library, NIH Natural Product Library, and NIH
Small Molecule Pharmacologically Active Library were separated using a seven minute
linear wateracetonitrile gradient (from 98:2 to 2:98 water:acetonitrile) containing 0.1%
formic acid. Compounds from NIH Clinical Collections and FDA Library part 2 Li-
brary employed a step gradient for chromatographic separation [5% solvent B (2:98
water:acetonitrile) containing 0.1% formic acid for 1.5 min, a step gradient of 5% B-50%
B in 0.5 min, held at 50% B for 2 min, a second step of 50% B-100% B in 6 min, held at
100% B for 0.5 min, 100%-5 % B in 0.5 min and kept at 5% B for 0.5 min]. The flow
rate was 0.5 mL/min. The mass spectrometer was operated in data dependent positive ion
mode; automatically switching between full scan MS and MS/MS acquisitions. Full scan
MS spectra (m/z 50 - 1500) were acquired in the TOF and the top ten most intense ions
in a particular scan were fragmented using collision induced dissociation (CID) utilizing
stepping.
B.0.6 GNPS Collections - Library Creation
All raw data were centroided and converted to 32-bit uncompressed mzXML file
using Bruker Data Analysis. A script was developed to select all possible MS/MS spectra
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in each LC-MS/MS run that could correspond to a compound present in the sample. For
each compound, we calculated the theoretical mass M from its chemical composition
and searched for the M+H, M+2H, M+K, and M+Na adducts. Putative identifications
included all MS/MS spectra whose precursor m/z had a ppm error <50 compared to
the theoretical mass of each possible precursor m/z; all tandem MS/MS spectra with
an MS1 precursor intensity of <1E4 were ignored. All candidate identifications were
manually inspected and the most abundant representative spectrum for each compound
was added to the corresponding library at the gold or bronze level based upon an expert
evaluation of the spectrum quality. The best MS/MS spectrum per compound as added to
the GNPS-Collections library without filtering or alteration from the mzXML files.
B.0.7 GNPS-Community Contributed Spectral Library Processing
and Control
User contributed library spectra are not filtered or altered in any way from the
user submission. MS/MS spectra are extracted from the submitted data and are made
available in the GNPS libraries. The list and description of metadata fields can be found
in GNPS online documentation. To preserve provenance information, the full input file is
also retained and made available for download for each library spectrum. Different levels
of reference spectra submissions are enforced with access restrictions on a per user basis.
The description of each of the quality levels: Gold, Silver and Bronze and be found in
Supplementary Table C.2. While any MS/MS spectrum can be Bronze quality level in
the GNPS libraries, Silver contributions require peer-reviewed publication of the MS/MS
spectra, and Gold contributions require MS/MS spectra to be of synthetics or purified
compounds with complete structural characterization.
Appendix C
GNPS Supplementary Information
C.0.1 Note 1: Browsing Available Libraries
All available libraries at GNPS, including freely available 3rd party libraries
can be browsed and or downloaded here. Users are able to see continually updated
snapshots of each of the respective libraries described in Supplementary Table C.1. User
instructions, available at gnps.ucsd.edu under documentation, for the Library Spectrum
View are be found under the appropriate sections.
C.0.2 Note 2: GNPS Library Addition Procedure (Collections and
Community)
To facilitate library growth, GNPS enables users to contribute to the GNPS-
Community spectral library from both private and public datasets. Reference spectra
can be uploaded as a set with a batch upload process, one spectrum at a time, or even
directly from the output of an analysis tool at GNPS with a single click Add To Library
button. The metadata fields that are required for user submissions and descriptions can be
found at gnps.ucsd.edu under documentation under the Library Contribution section. All
provenance information is automatically maintained so that proper credit can be given
in follow-up analysis. Even with Gold, Silver, and Bronze quality levels in place, it is
possible that i) some submissions will be tentative (especially in the Bronze category), ii)
81
82
some spectra will not yet have the highest possible signal (e.g., low abundance NPs), or
iii) metadata might be incomplete at the time of submission (e.g. tentative structures).
Therefore a wiki-style Update Annotation workflow is available, providing a path for
annotations of library spectra to become more complete. This revision approach enables
annotation updates for example from a hypothetical sugar containing natural product to
a much more specific Erythromycin when new information becomes available and can
also be used to fix incorrect or imprecise annotations. Also, missing metadata, such as
complete structural information, can be added to further complete annotation of library
spectra. To date 376 annotations been updated. Further, to reach a community consensus
on certain annotations, a data centric exchange may need to occur. GNPS promotes
these conversations by allowing comments on annotations with additional supporting
information attachments.
C.0.3 Note 3: Library Search False Discovery Rate Estimation
With library search being an integral part of molecular networking, dereplica-
tion, and continuous identification, it is important to assess the false discovery rates
of the library search available at GNPS. The massive datasets MSV000078708 and
MSV000078710 are the full LC-MS/MS runs for to create the NIH Natural Product and
NIH Small Molecule Pharmacological Libraries. They total 1,327,215 MS/MS query
spectra. The dynamic exclusion settings were to fragment a precursor at most three times
unless the MS1 peak intensity increased 2x since the last MS2 acquisition. This ensured
that there are multiple MS2 spectra per precursor. Further details can be found in Methods.
These datasets were searched against the NIH Natural Product and NIH Small Molecule
Pharmacological Libraries. The matches returned were categorized into the following:
identity match, consistent correct match, inconsistent correct match, and incorrect match.
Identity matches were matches between the library spectrum and the identical spectrum
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in the data that was extracted to create the library spectrum. Consistent Correct matches
are between library spectra and query spectra where the query spectrum occurred in the
same LC-MS/MS run as the library spectrum. Inconsistent Correct matches are between
library spectra and query spectra such that the ppm error of the match is <50ppm and
are within 200 scan numbers of each other, but the library and query did not come from
the same LC-MS/MS file. These could have resulted from contamination and impurities
in compound library. All other matches are considered incorrect. The 50ppm tolerance
and 200 scan thresholds were chosen based on the empirical match data. We took all
library spectra and matched them to all MS/MS query spectra with a 2 Da precursor
tolerance. The top scoring match for each query spectrum was reported if the match
score exceeded 0.7. The distribution of all possible ppm precursor m/z errors are shown
in Supplementary Figure 3.1a. For all of these matches that were reported, the ppm
precursor m/z error histogram is shown in Supplementary Figure 3.1b. With the possible
ppm errors of reported matches ranging beyond 10,000, the reported matches having
almost all PPMs below 50 is in indication the scoring scheme is discriminating between
true and false matches. Further, scan number deltas for all possible matches are shown
in Supplementary Figure 3.1c, which again shows a high variance in the possible deltas
that could occur. However, of the reported matches, the scan number delta converges
significantly as shown in Supplementary Figure 3.1d with nearly all of the identifications
occurring under a scan delta of 200 ( 5% of the chromatographic time). The spectral
library search at GNPS returned 8,355 matches, of which 2,428 were Identity matches,
4,557 were Consistent Correct matches. 1,138 were Inconsistent Correct matches, and
232 were incorrect matches. We calculated the false discovery rate to be 3.9% as the
number of incorrect matches divided by the total number of correct identifications with
the identity matches removed. Further, to show the sensitivity of the search, the library
included a total of 2,716 MS/MS spectra. Of which, 2,428 library spectra matched to
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the identical spectra used to create the library. Thus, 288 of the library spectra were
not matched because they did not meet the minimum number of peaks required to be
considered identifiable (6 peaks). Of the 2,428 library spectra that were deemed identifi-
able, 2,045 library spectra had at least one replicate identification (Supplementary Fig.
2). This allows us to estimate the sensitivity of the search at 84% by dividing the total
number of library spectra that had at least one correct non-identity match (2,045 spectra)
by the number of library spectra that had an identity match (2,428 spectra).
C.0.4 Note 4: GNPS Dataset Creation and Access
Entire project data sets, irrespective of size and number of data files, can be
uploaded, managed, analyzed, and shared with the entire community. Each of these
public dataset is given a unique identifier that can be referenced and linked in journal
articles. A variety of open file formats (mzXML, mzML, and MGF) as well as several
proprietary file formats can be uploaded to the system. Public datasets will be made
available in their original submission format and in an open format that is compatible
with all GNPS tools shortly after dataset publication. This process usually takes 48 hours
and availability status is shown on the dataset page under the heading Analyze Data.
Since GNPS datasets will be public and compatible with GNPS tools, public datasets can
be re-analyzed online. While metadata such as PI and username are required, metadata
such as protocols and similar details can be provided but are not mandatory (though can
be updated in the future). For further documentation regarding dataset creation, dataset
browsing (including downloading data, online re-analysis of data, and viewing continuous
identification results), see the appropriate section in the GNPS online documentation
(available at gnps.ucsd.edu under documentation).
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C.0.5 Note 5: Public Data Molecular Networks
All public NP datasets were clustered1, producing consensus spectra as described
in Methods Molecular Network Construction. For each dataset, the Identified Molecules
is the number of consensus spectra matched to a library spectrum by continuous identifi-
cation. The Putative Analog Molecules is the number of consensus spectra that had an
edge in the molecular network to a library matched consensus spectrum. The Identified
Networks is the number of consensus spectra that were a part of connected components
(node count>1) in the molecular network that had at least one consensus spectrum match
to a library spectrum. The Unidentified Networks is number of consensus spectra that
were a part of connected components (node count >1) in the molecular network that
did not have any matches to library spectra. The Exploratory Networks is the number
of consensus spectra that were a part of connected components (node count >1) in the
exploratory molecular network (Fig. 3.4a). The overall public data identification rate was
Identified Molecules summed across all datasets divided the total number of consensus
spectra across all datasets (Fig. 3.4b).
C.0.6 Note 6: Continuous Identification Procedure
Each single public GNPS dataset is run through the standard Molecular Net-
working workflow. The clustered set of spectra are then searched against the GNPS-
Collections, GNPS-Community, MassBank, ReSpect, and NIST libraries with the molec-
ular library search workflow. The most current search results are then compared with
the previous continuous identifications on a per dataset basis. Any changes in matches
(New, Different, or Deleted) are reported. Matches for previously unidentified spectra
are defined as New. Changes in matches of spectra due to annotation updates or a better
library match are defined as Different. Spectra that previously had a match but currently
do not due to removal of library spectra or updates to library search scoring functions are
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defined as Deleted. These results are reported in two different ways: i) all are shown on
the GNPS Dataset page under the Continuous Identification section ii) users subscribing
to each dataset are emailed a summary of changes in identifications (Each user receives
only one email with all summaries to avoid spamming). An email is only when a change
or new entry is obtained for a dataset to which a user is subscribed to.
C.0.7 Note 7: Molecular Explorer Creation and Presentation
All Continuous Identification matches are aggregated and grouped by matched
compound name. The GNPS Molecular Explorer presents all matched library compounds
and their respective occurrences in the public data. Thus, it is possible to easily ask
the question in which public datasets contain a certain molecule. Further, since GNPS
also constructs molecular networks for public datasets, the molecular explorer also
presents occurrences of putative analogs of library compounds. Supplementary Figure
C.6 highlight the amount of diversity of analogs captured by the molecular explorer as
well as the fraction of this diversity that is already captured by reference spectra in GNPS
spectral libraries. For further instructions, see the Molecular Explorer section GNPS
online documentation.
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Table C.1. GNPS Libraries Summary. Current spectral libraries available at GNPS,
including compound libraries run exclusively for GNPS, community contributed spectra,
and 3rd party libraries. Note: Original numbers created for the manuscript are inconsistent
with this table as updated numbers were generated 3/21/2016.
Library Name #Spectra #Compounds Data Generators
GNPS-Community 2,224 1,325 Community
GNPS-Collections (FDA Approved
Libraryfrom Selleck Chem Pt 1) 2,389 297 Sirenas MD
GNPS-Collections (FDA Approved
Libraryfrom Selleck Chem Pt 2) 656 535 Dorrestein Lab
GNPS-Collections (NIH
Clinical Collection 1) 377 329 Dorrestein Lab
GNPS-Collections (NIH
Clinical Collection 2) 195 164 Dorrestein Lab
GNPS-Collections (Natural Products
in NIH Small Molecule Repository) 1,268 1,255 Dorrestein Lab
GNPS-Collections (Pharma Active
Compounds in the NIH Small Mol Rep 1,460 1,398 Dorrestein Lab
GNPS-Collections (Prestwick
Phytochemical Library) 143 140 Dorrestein Lab
GNPS-Collections
(Faulkner Legacy Library) 127 125 Sirenas MD
MassBank ESI MS/MS Library
(Feb 2016) 24,545 5,992 Various
ReSpect MS/MS Library (July 2014) 7,112 1,986 Various
HMDB (Feb 2015) 2,235 747 Various
NIST 2014 ESI MS/MS Library 193,119 8,351 NIST
Total 235,850 22,644
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Table C.2. Library Quality Levels Description. The general public is granted access
to add to the Bronze quality levels. However, special permissions are required to have
access to add to Silver and Gold level MS/MS spectra. The oversight of these permissions
falls under the administrators of GNPS, and currently is managed by Pieter Dorrestein.
Quality Level Description Spectra
Count
Gold Synthetic or purified, Complete structural
characterization with NMR, crystallogra-
phy or other standard methods as defined
in the publication guidelines for Journal of
Natural Products. Requires administrative
approval.
4308
Silver Isolated or lysate/crude, Published data
showing presence of molecule in the sam-
ple. Requires administrative approval.
Recommended attendance of GNPS cu-
rator workshop.
446
Bronze Any other putative, complete, or partial
annotation
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Table C.3. Number of Annotation Revisions. This table summarizes the total number of
spectra with a given number of annotation revisions. There are a total of 563 annotation
revisions for 429 GNPS library spectra.
Number of Annotation Revisions Number of Library Spectra
1 351
2 46
3 19
4 7
5 4
6 0
7 1
8 1
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Figure C.1. Spectral Library Search Match Assessment. (a) The PPM error of all
possible matches from the NIH Natural Product Library and NIH Pharmacologically
Active Library to the query datasets MSV000078708 and MSV000078710. The spread
of possible PPM errors for all possible matches illustrates the large possible space of
erroneous matches as measured by PPM error. (b) The PPM errors of all reported matches.
There is a slight bump around 350PPM as all LC-MS/MS runs from one of the plates
was miscalibrated. The total number of non-identity matches that within 50 PPM error
is 5,520 matches out of a 5,927 matches. (c) The scan deltas of all possible matches
between the query spectra and library spectra. The large spread of possible scan number
deltas illustrates large possible space of erroneous matches as measured by scan number
deltas. (d) A histogram of scan number delta between query and library reported matches
by library search. 5,789 of all 5,927 matches reported fell within 200 scans of the library
spectrum.
Table C.4. Rating Description. Description of each of the ratings for matches made in
continuous identification.
Rating Description
1 Star Incorrect Identification
2 Star Not enough information, fragmentation is not sufficient to tell
3 Star Putative Analog Identification, possibly not exactly correct isomer
4 Star Correct Identification
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Figure C.2. Replicate Count Histogram within Reported Matches. A histogram of the
number of replicates for each library spectrum. These do not include identity matches or
incorrect matches.
Figure C.3. Chemical Space Visualization with Molecular Networking. MS/MS data
from a human skin metabolomics datasets (Bouslimani et al. 2015, MassIVE dataset
MSV000078556) was analyzed with molecular networking at GNPS. Consensus MS/MS
spectra matched to a GNPS library spectrum are highlighted as red nodes, unmatched in
grey.
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Figure C.4. Example Continuous Identification Digest Email. Digest email reporting
new identifications per dataset. For each dataset, the spectral match changes are reported
as well as total match count, links to results, and links to each dataset.
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Figure C.5. GNPS Collaboration Initiation. (a) For each public dataset, GNPS provides
a list of related datasets. This allows users to find related datasets to their own in order to
spark collaboration. In selecting a related dataset, users reach a dataset page (b). From
here more detailed metadata including an email link are available to initiate contact. (c)
Further, identifications made via continuous identification link to spectrum library pages
and enables users to initiate contact with the annotators of these library spectra.
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Figure C.6. Molecular explorer highlights the number and locations of related MS/MS
spectra of known compounds, indicating they are related (defined as analogs). Analogs
are direct neighbors of matched compounds in molecular networks. For each library
compound we tallied the number of unique mass analogs. Here we illustrate exactly how
much diversity of known compounds is found in all public GNPS datasets and how much
of that diversity is actually captured in the GNPS spectral libraries. For each library
spectrum matched to public data all unique mass analogs were counted (X axis) and all
unidentified analogs were counted (Y axis); the relationship between these is shown as a
2D heatmap. Since most of the density of the plot is near the diagonal, it indicates that the
majority of the putative analogs of known compounds in the data remained unidentified.
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Figure C.7. Dataset fold increase in identifications by continuous identification. The
fold increase of identifications on a per dataset basis from the time of deposition to
date. 59% of these datasets increased their identifications, averaging a 143% increase in
identifications since deposition.
Appendix D
MassIVE-KB Supplementary Informa-
tion
D.0.1 Online Library Creation
The CCMS spectral library can be augmented in an incremental manner. When
new datasets become available, they are automatically searched, PSMs extracted, and
augmented to the existing library. The resulting spectral library from a series of augmen-
tations is order agnostic, thus resulting in identical libraries given any permutation of
augmentations. An augmentation of new spectra can only result in the loss of precursors
from the library with the addition of new decoy spectra. The lost target precursors will
always be from the lowest scoring precursors. This stability is in contrast to SpectraSTs
construction process, where precursors can be lost if new additions become too similar to
existing library entries regardless of the confidence of the identifications.
D.0.2 Database p-value Calculation
The primary score for all PSMs is the database p-value[35]. The database p-value
captures the probability of at least one high scoring false match to a given spectrum in a
database size N. Lower database p-values indicate low error.
The equation to calculate the database p-value is as follows:
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1− (1−P(S|T ))N
P(S|T ) represents the spectral probability[49], i.e. the probability of a random
peptide match to spectrum S with a score higher than T . This value captures the how
good of a match a given peptide matches a spectrum S, with smaller values being a better
explanation. (1−P(S|T )) represents the probability of a random match with low score.
N represents the size of the database, i.e. the total number of candidates that are eligible
to match against the spectrum S. 1− (1−P(S|T ))N is the probability that all random
database matches are of low score. Then the final expression 1− (1−P(S|T ))N is the
probability that at least one random database match to spectrum S exceeds score T . Since
lower database p-values indicate higher confidence, we can aim to lower the database
p-value in several ways: decreasing spectral probability P(S|T ))) and decreasing database
size (N). To decrease spectral probability, by acquiring higher quality spectra or finding
a peptide that better explains the data accomplishes this goal. To decrease the database
size in samples where the true set of peptides and proteins that occur is unknown, we
discover the appropriate database (Fig. D.1a, D.2a). When the database is known, e.g.
synthetic peptide pools, we specifically constrain the database size and calculate the
database p-value appropriately (Fig. D.1b).
D.0.3 Dynamic Search Space Adjustment for Proteome Limited
Data
The dynamic adjustment of search space for these affinity purification mass
spectrometry files on average filtering the search space from ∼ 70K proteins in the
Uniprot Human Reference database down to approximately 1,500 proteins (Fig. D.2b).
PSMs that matching to these proteins will have their scores boosted because of the
reduced search space while all other PSMs scores will remain unchanged. Because of
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the requirement that two distinct sequences much match to a protein for the protein to be
included in the second pass search set, a single PSM will not boost its own score, rather a
second distinct PSM of a different sequence is required.
By appropriately adjusting the search space for the samples from Bioplex, the
MassIVE-KB spectral library increased by 172K precursors (8% of the MassIVE-KB
library and 35% of Bioplex’s unique precursors).
D.0.4 Database Identification of Synthetic Peptide Pools from
ProteomeTools
Each LC/MS run of the 365 peptide pools from ProteomeTools is searched
separately against the appropriate peptide database. Due to scheduled acquisition of
MS/MS spectra, there existed very few background MS/MS that would not match to
the database, decreasing the probability for any decoy spectra. We included 10 random
LC/MS runs from different peptide pools, i.e. including completely different peptides, as
background spectra for decoys.
Decoy PSMs are PSMs from any LC/MS run that matched to a reverse decoy
database and PSMs from the background LC/MS runs that matched to the target database.
Because of this expanded definition of decoy PSMs that can come from true target
sequences, we cannot include these decoy PSMs in the library. Therefore, we have
conservatively filtered to 0% empirical PSM FDR.
D.0.5 Global Error Rate Controls for Spectral Library
To control accumulation of errors in repository wide aggregation of identification
results, we globally controlled error rates at the precursor and protein levels. Per search,
we controlled FDR at 1% PSM level, however, if we naively aggregated all of the PSMs
to form a library, the precursor FDR would grow to 28%. We control this precursor FDR
by filtering to 1% local precursor FDR by length. Each precursors score is the best score
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of any PSM from that precursor. All precursors are grouped by length and then sorted by
decreasing score (-log(database p-value)). Local FDR is determined for each precursor
as the FDR of a sliding window of 500 adjacent precursors.
Following that, we calculated a picked protein FDR and retained only precusros
that mapped (including shared) to proteins falling below 1% FDR. A proteins score is the
summation of all uniquely mapping precursors -log(database p-value).
While we did choose to filter to 1% PSM level FDR per search before aggregation,
all candidate spectra that could be representatives spectra in the MassIVE-KB spectral
library uniformly had a per search FDR of 0%. This indicates that we could have chosen
a 0% PSM level FDR per search and would not change the resulting library. However,
not including decoys would not enable us to determine a library FDR.
D.0.6 Decoy Inclusion in Spectral Library
The source of errors in spectral library search identifications arise from erroneous
spectral matches and incorrect identifications of library spectra. The former is captured
by spectral decoys[57] in library search, but the latter is ignored to exist. Database search
decoys are carried throughout the library search process to this type of error. Thus, this
introduces another class of decoys for library search to consider. We have implemented
this awareness into an MSPLIT workflow that is available to use online at the CCMS.
While the MassIVE-KB library contained only 1,910 (0.09% of library) decoy precursors,
these decoys constituted 6% of the decoy matches (Fig. D.6), an over-representation of
over 60x.
D.0.7 Library Representative Selection
In choosing the most similar spectrum to all other spectra in general also chose
the highest scoring spectra, but not necessary all of the time (Fig. Spectral Quality b). In
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nearly all cases however, the top 10 scoring spectrum was chosen. By choosing the most
similar spectrum, an improvement in spectral similarity is observed when compared to
the gold standard SILAC spectral library (Fig. D.2). Further, the representative selection
criteria yielded MS/MS spectra that exhibited similarity to the SILAC library at least as
good as the NIST HCD spectral library (Fig. D.4a).
D.0.8 Spectral Library Search
The MassIVE-KB spectral library is distributed both as an MGF and sptxt format
for use in various tools. In its MGF format, it is directly compatible with the MSPLIT
spectral library search workflow available at CCMS. A HEK293 dataset[13] containing
1.1M MS/MS spectra was searched with both the MassIVE-KB library and NISTs HCD
library. Though this dataset was used in creating the MassIVE-KB spectral library,
any from this dataset was removed from the MassIVE-KB for these search purposes.
MassIVE-KB increased precursors (at 1% precursor FDR) identified from 77,472 to
127,419 (Fig. D.6), a 64% increase.
D.0.9 Proteins in Dataset
There are 1,270 proteins observed that included less than two non-overlapping
sequences that did not match to a single SAAV in the proteome. 394 of these proteins
occur in the Bioplex dataset. 112 of these proteins were bait proteins and 283 did contain
two or more unique peptides without considering SAAVs in the proteome. These lines
of evidence give credence that these protein identifications are correct. However, the
remaining 95 proteins did only have one unique peptide and were not included in baits
and potentially could be false identifications. However, out of the 12K proteins in the
Bioplex dataset, if these 95 proteins were indeed false discoveries, it would represent
a 0.7% FDR, in-line with the global 1% Protein FDR that was applied during library
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Figure D.1. Technical Search Overview. (a) Illustration of search strategy for protein
constrained dataset (e.g. affinity purification). Spectra are first searched against the
full proteome and PSMs are filtered to 1% PSM level FDR. Proteins with two or more
peptides are collected. Input spectra are re-scored against this reduced protein set to
update database p-values for spectra identified to these proteins in both stages. Results
are filtered to 1% PSM level FDR to retain enough decoys for estimation of library-level
FDR. (b) Synthetic peptide data is searched against the appropriate peptide database
along with a random synthetic peptide run. All identifications from the target peptide
pool data is considered targets and identifications to the random peptide pool data are
considered decoys. All PSMs are ranked by their database p-value scores and all PSMs
with a q-value greater than 0 are dropped.
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Figure D.2. Search Space Score Adjustment. (a) The appropriate search space for a mass
spectrometry dataset can vary widely based on experimental procedures. These search
spaces range from nearly full proteome for cell lysates down to a handful of peptides for
synthesized peptide pools. By appropriately determining this search space for cell lysate,
affinity purification, and synthetic peptide pools, database p-value scores improved by
∼ 0.3, ∼ 1.6, and ∼ 3.2 orders of magnitude respectively. (b) Each bait in the Bioplex
AP-MS dataset was searched separately. The distribution of proteins used in refined
search space is centered around approximately 1,500 proteins.
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Figure D.3. Size Comparison to NIST. The shared and unique sequences in CCMS
vs NISTs libraries. While NIST contains 50K unique sequences not contained in the
MassIVE-KB libraries, the majority are short peptides (<9 amino acids). In contrast,
the gains in sequences in MassIVE-KB library over NIST are predominantly sequences
length that are most commonly observable and identifiable in mass spectrometry.
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Figure D.4. MassIVE-KB Library Quality. (a) Spectral similarity of annotated ions in
NIST and MassIVE-KB spectral library compared to SILAC gold standard library. Shown
in red is the distribution of cosine scores between light and heavy SILAC MS/MS spectra
in the SILAC dataset, representing the expected best similarity that can be expected from
replicates. (b) The chosen representative library spectrum score rank of all considered
spectra. In greater than 90% of cases, the representative spectrum was in the top 20
spectra. (c) The number of peptide identifications for each library spectrum. Only 2.5%
of library spectra were called ambiguous (two or more identifications) and were removed
from the MassIVE-KB spectral library. (d) PPM error of library spectra.
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Figure D.5. Selection Methods for Representative. In comparison to the SILAC gold
standard library, the the most similar representative spectra to all other replicates exhibits
a better cosine similarity to the gold standard library compared with the highest scoring
replicate spectrum.
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Figure D.6. Massive-KB Library Identification Rate. (a) The MassIVE-KB HCD
spectral library when searching a HEK293 Q-Exactive dataset (PXD001468) increases
the number of precursors identified by 64% (1% Precursor FDR) over NISTs HCD library.
MassIVE-KBs identified 127,419 precursors and NISTs HCD library identified 77,029
precursors. (b) The 21,602 precursors uniquely identified by the NIST HCD library
trended toward shorter peptides that were missing from the MassIVE-KB library.
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